Prof. laron's publications

(for digital or scaned copies, please contact the library)

 30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. EFFECTS OF PHYSICAL & BIOCHEMICAL CHANGES 1ft GH DEFICIENT PATIENTS (GHD) AFTER INTERRUPTION OF hCH THERAPY AT FINAL HEIGHT AND RETREATMENT IN ADULTHOOD. Hormone Res. 1991;35(Suppl. 2):Abstract 109. – Please contact the medical library for a copy.  30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. PREDISPOSITION TO HYPERTENSION AND PERSISTENT MICROALBU- MINUR1A IN TYPE 1 DIABETIC YOUNGSTERS. Hormone Res. 1991;35(Suppl. 2):Abstract 33. – Please contact the medical library for a copy.  30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. MODULATION OF 1GF-I RECEPTORS BY hCH TREATMENT OF CONSTITUTIONALLY SHORT CHILDREN (CSS). Hormone Res. 1991;35(Suppl 2):Abstract 146. – Please contact the medical library for a copy.  30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. PROLACTIN RESPONSE TO i.v. IGF-1 AND TRH STIMULATION IN LARON TYPE DWARFISM (LTD) PATIENTS’AND CONTROLS. Hormone Res. 1991;35(Suppl. 2):Abstract 147. – Please contact the medical library for a copy.  30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. FINAL HEIGHT IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY (CPP) TREATED WITH THE Gn-RH AGONIST D-TRP-6-LHRH. Hormone Res. 1991;35(Suppl. 2):Abstract 151. – Please contact the medical library for a copy.  30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. rIGF-I DEPLETES HYPOTHALAMIC SOMATOSTATIN (SS) AND GHRH STORES AND INHIBITS CH PULSATILE RELEASE IN THE RAT. Hormone Res. 1991;35(Suppl. 2):Abstract 48. – Please contact the medical library for a copy.  30th annual meeting of the European Society for Paediatric Endocrinology (ESPE). Berlin A 25-28 1991. MEASUREMENT OF HUMAN SERUM GROWTH HORMONE BINDING PROTEIN (GHBP) BY RIA COMPARED WITH GEL FILTRATION. Hormone Res. 1991;35(Suppl. 2):Abstract . – Please contact the medical library for a copy.  Abramovici A, Josefsberg Ζ, Mimouni M, Liban E, Laron Z. Histopathological Features of the Skin in Hypopituitarism and Laron-Type Dwarfism. Israel Journal of Medical Sciences. 1982;19:515-519. – Please contact the medical library for a copy.  Abramovici A, Nevo Z, Stuhlsatz H, Greiling H, Mimouni M, Laron Z. Biochemical and histopathological changes in hypophysectomized rat skin. In: Biochimie Des Tissues Conjonctifs Normaux et Pathologiques. ; 1980:267-272. – Please contact the medical library for a copy.  Adler-Bier M, Pertzeland A, Laron Z, Lieberman E, Moses S. Multiple pituitary hormone deficiencies in eight siblings of one Jewish Moroccan family. Acta Paediatr Scand. 1979;68(3):401-404. doi:10.1111/j.1651-2227.1979.tb05027.x. – Please contact the medical library for a copy.  Aizenberg D, Hermesh H, Gil-ad I, et al. TRH stimulation test in obsessive-compulsive patients. Psychiatry Res. 1991;38(1):21-26. doi:10.1016/0165-1781(91)90049-u. – Please contact the medical library for a copy.  Amir S, Galatzer A, Frish M, Laron Z. A sociological survey of 296 juvenile diabetics. Psychological Aspects of Balance of Diabetes in Juveniles. Pediatric and Adolescent Endocrinology. 1977;3:82-89. – Please contact the medical library for a copy.  Amir S, Galatzer A, Karp M, Laron Z. The young diabetic subjects in the Israel army. Diabete et Metabolisme. 1994;20(3):297-302. – Please contact the medical library for a copy.  Amir S, Galatzer A, Laron Z. Effects of various occupations on nutrition habits and diabetic management. In: Nutrition and the Diabetic Child. Pediatric & Adolescent Endocrinology. Vol. 7. ; 1979:133-139. – Please contact the medical library for a copy.  Amir S, Galatzer A, Laron Z. Psychosocial problems in diabetic children, adolescents and their families. 3rd international ISDG course on update on diabetes in childhood. 1991:97-102. – Please contact the medical library for a copy.  Amir S, Kaplan Y, Aran O, Galatzer A. {Psycho-social intervention in the treatment of juvenile diabetes at the clinic, home and community: recent progress in medio-social problem in juvenile diabetes}.‏ Pediatr Adolesc Endocrinol11:97-101;1983‏..‏ – Please contact the medical library for a copy.  Amir S, Rabin C, Galatzer A, Laron Z. Interaktionen zwischen medizinischem Team und Patienten bei Diabetikern und ihre Compliance. In: Roth R, Borkenstein HM, eds. Psychosoziale Aspekte in Der Betreuung von Kindern Und Jugendlichen Mit Diabetes: 7. Tagung Des Arbeitskreises “Diabetes Und Psychologie”, Graz, April 1990. S. Karger AG; 1991:127-137. doi:10.1159/000420519– Please contact the medical library for a copy.  Ann. Meeting of the Israel Endocrine Society. Effect of oral clonidine and insulin induced hypoglycemia on plasma somatostatin levels in short stature boys. (Abstract). Israel J Med Sci. 1991;(27):356. – Please contact the medical library for a copy.  annual meeting of the american endocrine Society P 73rd. Effect of short term therapy with rIGF-l on thyroid function in patients with Laron type dwarfism. proc 73rd annual meeting of the american endocrine society. 1991;June:Abstract 426. – Please contact the medical library for a copy.  annual meeting of the american endocrine Society P 73rd. Metabolic changes in GH deficient patients after interruption of hGH treatment at end of puberty and re- institution in adult age. proc 73rd annual meeting of the american endocrine society. 1991;June:Abstract 1309. – Please contact the medical library for a copy.  Apter A, Dickerman Z, Gonen N, et al. Effect of chlorpromazine on hypothalamic- pituitary-gonadal function in 10 adolescent schizophrenic boys. Am J Psychiatry. 1983;140(12):1588-1591. doi:10.1176/ajp.140.12.1588.– Please contact the medical library for a copy.  Apter A, Galatzer A, Weizman A, Weizman T, Modai I, Laron Z. Psychological aspects of developmental endocrinopathies in adolescence. Israel Journal of Psychiatry and Related Sciences. 1994;31(4):246-253. – Please contact the medical library for a copy.  Aran O, Bet-halachmi N, Nofar E, Pertzelan A, Laron Z. {Approach of parents to children with marked short stature — comparison between two families (Hebrew).}. The Family Physician. 1982;11:55-60. – Please contact the medical library for a copy.  Aran O, Galatzer A, Kauli R, Nagelberg N, Robicsek Y, Laron Z. Social, educational and vocational status of 48 young adult females with gonadal dysgenesis. Clin Endocrinol (Oxf). 1992;36(4):405-410. doi:10.1111/j.1365-2265.1992.tb01467.x– Please contact the medical library for a copy.  Aran O, Laron Z, Galazer A, Nagelberg N, Rubicsek Y. Is short stature a handicap - legal and rehabilitation aspects. In: Limb Lengthening: For Whom, When and How?. ; 1995:131-135. – Please contact the medical library for a copy.  Asherov J, Mimouni M, Laron Z. Successful treatment of insulin lipoatrophy. A case report. Diabete Metab. 1979;5(1):1-3. – Please contact the medical library for a copy.  Asherov J, Mimouni M, Varsano I, Lubin E, Laron Z. Hepatomegaly due to self induced overinsulinism. Arch Dis Child. 1979;54:148-149.  Assa S, Benjamini Y. Insulin antibody assay: a statistical evaluation of sensitivity, precision and reproducibility in healthy subjects. Br J Biomed Sci. 1993;50(2):103- 108. – Please contact the medical library for a copy.  Assa S, H M. Elevated serum placental isoferritin in newly diagnosed IDDM patients. A possible marker for identification of high risk subjects. journal of pediatric endocrinology. 1991;4(3):Abstract 25. – Please contact the medical library for a copy.  Assa S, Karp M, Erster B, Laron Z. Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives. Israel journal of medical sciences. 1985;21(9):727-730. – Please contact the medical library for a copy.  Assa S, Moroz C. Elevated serum placental isoferritin in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. A possible marker for identification of high risk subjects. Diabetologia. 1990;33(9):557-560. doi:10.1007/bf00404144  Assa S, Peleg S, D E, R C, Z L. Lack of anti-idiotypic antibodies in childhood IDDM. J Pediat Endocrinol. 1991;4(3):Abstract 26. – Please contact the medical library for a copy.  Assa S, Peleg S, Gafny M, Z.Laron. No anti-idiotypic antibodies to anti-insulin idiotypes in newly diagnosed Type 1 (insulin-dependant) diabetes mellitus. In: Laron Z, Karp M, eds. Genetic and Enviromental Risk Factors for Type I Diabetes (IDDM) Including a Discussion on the Autoimmune Basis1992:119-121.‏ – Please contact the medical library for a copy.  Attias J, Negeris B, Zarhi O, Laron Z. Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy (Abstract #P-55). GH and IGF Res. 2008;18(Suppl. 1):S43. – Please contact the medical library for a copy.  Attias J, Negeris B, Zarhi O, Z. L. Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy. (Abstract #P1-d3-283). Horm Res. 2008;70(Suppl. 1):84.  Attie KM, Bengtsson BA, Blethen SL, et al. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society. J Pediatr Endocrinol Metab. 2001;14(4):377-382. – Please contact the medical library for a copy.  Attie KM, Bengtsson BA, Blethen SL, et al. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society. Journal of Clinical Endocrinology and Metabolism. 2000;85(11):3990-3993.  Barel-Graf H, Klinger B, Anin S, Laron Z. Foot length in untreated and GH-treated hereditary GH deficient patients. Endocrinology and Metabolism, Supplement. 1994;Suppl. B(Abstract P.069):35. – Please contact the medical library for a copy.  Beit-Halachmi N, Kaplan Y, Laron Z, Karp M, Galatzer A. Impact of diabetes mellitus on healthy siblings. In: Psychological Aspects of Diabetes in Children and Adolescents. Pediatric & Adolescent Endocrinology Vol. 10. ; 1982:114-122. – Please contact the medical library for a copy.  Beith-Halachmi N, Galatzer A. Rehabilitation status of young adults with juvenile diabetes mellitus. In: Progress in Medico-Social Problems in Juvenile Diabetics. Pediatric & Adolescent Endocrinology Vol. 11. ; 1982:58-63. – Please contact the medical library for a copy.  Ben-Amitai D LZ. Insulin-like growth factor-1 (IGF-1) deficiency prevents the appearance of pre-acne and acne. Horm Res Paediatr. 2009;72(3):265-266. – Please contact the medical library for a copy.  Ben-Amitai D, Laron Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. J Eur Acad Dermatol Venereol. 2011;25(8):950-954. doi:10.1111/j.1468-3083.2010.03896.x  Benbassat C, Eshed V, Kamjin M, Laron Z. Are patients with Laron syndrome (LS) osteoporotic? (Abstract #P2-360). Proceedings of the 85th Annual Meeting of The Endocrine Society. 2003:393. – Please contact the medical library for a copy.  Benbassat C, Eshed V, Laron Z. Are patients with Laron syndrome (LS) osteoporotic? (Abstract #P72). Annual Meeting of the Israel Endocrine Society. 2003:Abstract #P72. – Please contact the medical library for a copy.  Benbassat CA, Eshed V, Kamjin M, Laron Z. Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities. J Clin Endocrinol Metab. 2003;88(10):4586-4589. doi:10.1210/jc.2003-030623  Benbassat CA, Wasserman M, Laron Z. Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency. Growth Horm IGF Res. 1999;9(5):290-295. doi:10.1054/ghir.1999.0118. – Please contact the medical library for a copy.  Ben-Dov I, Gaides M, Scheinowitz M, Wagner R, Laron Z. Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome). Clin Endocrinol (Oxf). 2003;59(6):763-767. doi:10.1046/j.1365-2265.2003.01920.x  Berg MA, Guevara-Aguirre J, Rosenbloom AL, Rosenfeld RG, Francke U. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. Hum Mutat. 1992;1(1):24-32. doi:10.1002/humu.1380010105. – Please contact the medical library for a copy.  Bergenfelz A, Ahrén B. Serum osteocalcin levels do not change during rapidly induced hypercalcemia in healthy subjects. Horm Res. 1992;37(1-2):29-32. doi:10.1159/000317346. – Please contact the medical library for a copy.  Biener J, Laron Z, Flechner I. Melphalan Attenuates Streptozotocin-Induced Diabetes in C57Bl/6 and C3H3 Mice. Israel Journal of Medical Sciences. 1988;24(3):190-191. – Please contact the medical library for a copy.  Blieden LC, Kuberger N, Goez R, et al. Non-traditional risk factors for atherosclerosis in high risk children. Israel Journal of Medical Sciences. 1996;32(12):1255-1261. – Please contact the medical library for a copy.  Bloom A, Galatzer A, Laron Z. Group counselling in juvenile diabetic patients. Harefuah. 1985;108:528-530. – Please contact the medical library for a copy.  Blum A, Galatzer A. Group counselling for diabetic patients. In: Psychological Aspects of Diabetes in Children and Adolescents. Pediatric & Adolescent Endocrinology Vol. 10. ; 1982:230-233. – Please contact the medical library for a copy.  Blum I, Doron M, Laron Z. Lack of influence of arginine preloading on the insulin response to I.V. glucagon in children and adolescents. Acta Diabetol Lat. 1978;15(1- 2):68-71. doi:10.1007/BF02581008. – Please contact the medical library for a copy.  Blum I, Rusecki Y, Doron M, Lahav M, Laron Z, Atsmon A. Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases. J Endocrinol Invest. 1983;6(1):41-45. doi:10.1007/BF03350559. – Please contact the medical library for a copy.  Bock G, Goode J, eds. Biology of IGF-1: Its Interaction with Insulin in Health and Malignant States: Novartis Foundation Symposium 262. Chichester, UK: John Wiley & Sons, Ltd; 2004. doi:10.1002/0470869976.– Please contact the medical library for a copy.  Bourla DH, Laron Z, Snir M, Lilos P, Weinberger D, Axer-Siegel R. Insulin-like growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome. Ophthalmology. 2006;113(7):1197.e1-5. doi:10.1016/j.ophtha.2005.12.023  Brat O, Ziv I, Klinger B, Avraham M, Laron Z. Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome. Horm Res. 1997;47(2):45-48. doi:10.1159/000185429. – Please contact the medical library for a copy.  Brat O, Ziv I, Klinger B, Laron Z. Muscle strength and endurance of untreated adult Laron Syndrome (LS) and young growth hormone deficiency (GHD) patients. Endocrinology and Metabolism, Supplement. 1994;1-Suppl.(Abstract P.071):36. – Please contact the medical library for a copy.  Brown MR, Meacham LR, Pfaffle R, et al. The Molecular Defect in Laron Syndrome: Exon Deletions. In: Z. L, Parks J, eds. Lessons from Laron Syndrome (LS), 1966-1992, A Model of GH and IGF-I Action and Interaction Vol. 24. Pediat. Adolesc. Endocrinol. Basel: S. Karger AG; 1993:127-131. – Please contact the medical library for a copy.  Carelli C, Hernandez B, Maor G, Z L, M G. The chimeric P7 peptide consisting of a GH fragment and somatostatin: A first structural analysis approach. (Poster). ENEA (Europ Neuro-Endocrinology Association. 2010;Meeting(Poster). – Please contact the medical library for a copy.  Carelli C, Maor G, Laron Ζ. Accelerating and inhibitory effects of a chimeric peptide consisting of somatostatin and a GH fragment. (Abstract P3-237). ENDO 2010. 2010. – Please contact the medical library for a copy.  Carmi D, Laron Z, Mahler Ch, Defoer FY. Ectopic thyroid in siblings. J Endocrinol Invest. 1991;14(2):151-151. doi:10.1007/BF03350290. – Please contact the medical library for a copy.  Carroll PV. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Journal of Clinical Endocrinology & Metabolism. 1998;83(2):382-395. doi:10.1210/jc.83.2.382  Cerasi E, Golander A, Laron Z. Growth hormone treatment in israel. Clin Pediatr Endocrinol. 1993;2(Supple2):1-3. doi:10.1297/cpe.2.Supple2_1  Chiarelli F, Verrotti A, Van Dyke D, et al. Sodium lithium countertransport activity in red cells of diabetic children and their parents. J Pediat Endocrinol. 1991;4(3):Abstract 72. – Please contact the medical library for a copy.  Clayton PE, Cohen P, Tanaka T, Hintz RL, Laron Z, Sizonenko PC. Diagnosis of growth hormone deficiency in childhood. On behalf of the Growth Hormone Research Society. Horm Res. 2000;53 Suppl 3:30. doi:10.1159/000023529  Cohen A, Kauli R, Pertzelan A, et al. Final height of girls with Turner’s syndrome: correlation with karyotype and parental height. Acta Paediatr. 1995;84(5):550-554. doi:10.1111/j.1651-2227.1995.tb13693.x. – Please contact the medical library for a copy.  Collado-Mesa F, Diaz-Diaz O, Ashkenazi I, Laron Z. Seasonality of birth and Type 1 diabetes onset in children (0-14 years) in Cuba. Diabet Med. 2001;18(11):939-940. doi:10.1046/j.1464-5491.2001.00590-3.x  Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology & Metabolism. 1998;83(2):379-381. doi:10.1210/jc.83.2.379  Dagan Y, Abadi J, Lifschitz A, Laron Z. Severe obstructive sleep apnoea syndrome in an adult patient with Laron syndrome. Growth Horm IGF Res. 2001;11(4):247-249. doi:10.1054/ghir.2001.0235. – Please contact the medical library for a copy.  Desai M, Choksi C, Colaco P, et al. Growth Hormone Insensitivity (GHI) Syndrome in the Indian Subcontinent. Joint Meeting Of International Society Of Diabetes In Children And Adolescents (ISPAD) and 4th Asian Symposium Of Childhood And Juvenile Diabetes. 1997. – Please contact the medical library for a copy.  Diabetes Epidemiology Research International Group. Geographic patterns of chidhood insulin-dependent diabetes mellitus. Diabetes. 1988;37(August):1113- 1119. – Please contact the medical library for a copy.  Diabetes Epidemiology Research International Study Group. Failure of Diabetes Care in America? Evidence from the DERI Mortality Study. Diabetes. 1993;42(Suppl. 1):Abstract 287: 91A. – Please contact the medical library for a copy.  Diabetes Mellitus. Clin Pediatr (Phila). 1978;17(9):727-730. doi:10.1177/000992287801700913. – Please contact the medical library for a copy.  DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med. 2006;23(8):857-866. doi:10.1111/j.1464- 5491.2006.01925.x  Dickerman Z, Bar-Haim Y, Prager-Lewin R, Kaufman H, Laron Z. Plasma LH and FSH response to LRH and plasma testosterone levels in boys with irregular puberty. Acta Endocrinol. 1977;85(3):459-464. – Please contact the medical library for a copy.  Dickerman Z, Bauman B, Sandovsky U, et al. Human chorionic gonadotropin (hCG) treatment in cryptorchidism. Andrologia. 1983;15 Spec No:542-547. doi:10.1111/j.1439-0272.1983.tb00209.x. – Please contact the medical library for a copy.  Dickerman Z, Cohen A, Laron Z. Growth in patients with isolated gonadotrophin deficiency. Arch Dis Child. 1992;67(4):513-516. doi:10.1136/adc.67.4.513  Dickerman Z, Landman J, Prager-Lewin R, Laron Z. Evaluation of testicular function in prepubertal boys by means of the luteinizing hormone-releasing hormone test. Fertil Steril. 1978;29(6):655-660.  Dickerman Z, Loewinger J, Laron Z. The pattern of growth in children with constitutional tall stature from birth to age 9 years. A longitudinal study. Acta Paediatr Scand. 1984;73(4):530-536. doi:10.1111/j.1651-2227.1984.tb09966.x. – Please contact the medical library for a copy.  Dickerman Z, Lubin E, Laron Z. The use of Cholesterol I in the investigation of two young Cushing patients. Proceedings of the 4th National Congress of Nuclear Medicine in Israel. 1976:67. – Please contact the medical library for a copy.  Dickerman Z, Prager-Lewin R, Lahmy O, Laron Z. Acceleration of puberty in boys with delayed puberty by clomiphene citrate. A clinical and laboratory study. Acta Endocrinol. 1980;94(1):117-125. doi:10.1530/acta.0.0940117. – Please contact the medical library for a copy.  Dickerman Z, Pragerlewin R, Laron Z, Prager-Lewin R, Laron Z. The plasma FSH and LH response to synthetic LH-RH in normal pre-pubertal and early pubertal girls: A reevaluation. Acta Endocrinologica. 1979;91(1):14-18. – Please contact the medical library for a copy.  Dickerman Z, Shuper A, Prager-Lewin R, Lahmy O, Laron Z. Induction of puberty in boys with delayed adolescence by methandrostenolone. Eur J Pediatr. 1980;135(1):59-64. doi:10.1007/bf00445894. – Please contact the medical library for a copy.  Domené H, Krishnamurthi K, Eshet R, et al. Growth hormone (GH) stimulates insulin- like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Endocrinology. 1993;133(2):675-682. doi:10.1210/endo.133.2.7688291. – Please contact the medical library for a copy.  E B, K M, Ross S, Josefsberg Ζ. Office hypertension in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34:684-685.  Eliash A, Roitman A, Karp M, et al. Diencephalic syndrome due to a suprasellar epidermoid cyst. Case report. Childs Brain. 1983;10(6):414-418. – Please contact the medical library for a copy.  Eshed V, Benbassat C, Lilos P, Laron Z. Effect of Fosamax on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity). (Abstract P1-520). Proceedings of the 86th Annual Meeting of The Endocrine Society. 2004:284. – Please contact the medical library for a copy.  Eshed V, Benbassat CA, Laron Z. Effect of alendronate on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity). Growth Horm IGF Res. 2006;16(2):119-124. doi:10.1016/j.ghir.2006.02.004  Eshet R, Duz Z, Silbergeld A, Koren R, Klinger B, Laron Z. Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I. Acta Endocrinol. 1991;125(4):354-358. doi:10.1530/acta.0.1250354– Please contact the medical library for a copy.  Eshet R, Klinger B, Silbergeld A, Laron Z. Modulation of IGF-I receptors by exogenous hGH treatment in constitutionally short children. Clin Endocrinol (Oxf). 1993;39(6):687-693. doi:10.1111/j.1365-2265.1993.tb02428.x. – Please contact the medical library for a copy.  Eshet R, Klinger B, Silbergeld A, Laron Z. Modulation of IGF-I receptors on RBC by IGF-I treatment in patients with Laron Syndrome (Abstract). In: Annual Meeting of the Israel Endocrine Society. ; 1993:55. – Please contact the medical library for a copy.  Eshet R, Klinger B, Silbergeld A, Laron Z. Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS). Regul Pept. 1993;48(1-2):233-239. doi:10.1016/0167- 0115(93)90352-9. – Please contact the medical library for a copy.  Eshet R, Klinger B, Werner H, Roberts CT, LeRoith D, Laron Z. Regulation of IGF-1 receptor activity in Laron Syndrome and in isolated growth hormone deficiency. Pediat Adolescent Endocrinology. 1993;24:209-215. – Please contact the medical library for a copy.  Eshet R, Laron Z, Brown M, Arnon R. Immunological behaviour of HGH from plasma of patients with familial dwarfism and high IR-HGH in a radioimmunoassay system using the cross-reaction between HGH and HCS. Horm Metab Res. 1974;6(1):80-81. – Please contact the medical library for a copy.  Eshet R, Laron Z, Brown M, Arnon R. Immunoreactive properties of the plasma hGH from patients with the syndrome of familial dwarfism and high plasma IR-hGH. J Clin Endocrinol Metab. 1973;37(5):819-821. doi:10.1210/jcem-37-5-819  Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci. 1984;20(1):8-11. – Please contact the medical library for a copy.  Eshet R, Laron Z, Silbergeld A, Diamant YZ, Gdansky E. Characterization of IGF-I receptors on erythrocytes (RBC) of women with polycystic ovarian syndrome (PCOS). (Abstract #376). Horm Res. 1996;46(Suppl. 2):95. – Please contact the medical library for a copy.  Eshet R, Peleg S, Josefsberg Z, Fuchs C, Arnon R, Laron Z. Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue. Horm Res. 1985;22(4):276-283. doi:10.1159/000180106. – Please contact the medical library for a copy.  Eshet R, Peleg S, Laron Z. Direct visualization of binding, aggregation and internalization of hGH in cultured human lymphocytes. Acta Endocrinol. 1984;107:9- 15. – Please contact the medical library for a copy.  Eshet R, Silbergeld A, Kauli R, Lazar L, Laron Z. GH and GHBP activity and not IGF-1 and its receptor activity express growth velocity reduction during treatment of central precocious puberty by a superactive GNRH analogue. Israel Journal of Medical Sciences. 1994;30(8):592-595. – Please contact the medical library for a copy.  Eshet R, Silbergeld A, Kauli R, Lazar L, Laron Z. Treatment of precocious puberty (PP) with GnRH analogue (GnRH-a) decreases IGF-I binding to its receptors on red blood cells (RBC). Horm Res. 1994;41(Abstract 173):100. – Please contact the medical library for a copy.  Eshet R, Silbergeld A, Zaizov R, et al. Decreased insulin-like growth factor-I receptor sites on circulating mononuclear cells from children with acute leukemia. Pediatric Hematology and Oncology. 2000;17(3):253-260. – Please contact the medical library for a copy.  Eshet R, Werner H, Klinger B, Roberts CT, Laron Z, LeRoith D. regulation of igf-i receptor gene expression in pbl of patients with long-term igf-i deprivation. Horm. Res. 1992;38(Supp 4):10. – Please contact the medical library for a copy.  Eugster EA, Pescovitz OH. Developmental Endocrinology. New Jersey: Humana Press; 2002. doi:10.1385/1592591566. – Please contact the medical library for a copy.  Faiman G, Flexer Z, Karp M, Galatzer A. {Nutritional pattern of diabetic children in Israel. A cross-sectional and longitudinal study}.‏ Nutrition and the diabetic child, 19797:51-55;1979‏..‏ – Please contact the medical library for a copy.  Faiman G, Topper E, Goldman J, et al. Dietary Adjustment During Self-Blood-Glucose Monitoring in Pregnant-Women With Insulin-Dependent Diabetes-Mellitus. Journal of the American Dietetic Association. 1984;84(7):816-817. – Please contact the medical library for a copy.  Farfel A, Afek A, Derazne E, Merlob P, Linder N, Laron Z. Anthropometric indices at age 17 years of full-term neonates born short. Arch Dis Child. 2009;94(12):959-961. doi:10.1136/adc.2009.158386  Farfel A, Afek A, Derazne E, Merlob P, Linder N, Laron Z. Prevalence of short stature and overweight at age 17 of children born short for gestational age (Abstract # P1- 779). 90th Annual Meeting of the American Endocrine Society. 2008;Program an:381. – Please contact the medical library for a copy.  Farfel A, Afek A, Derazne E, Merlob P, Linder N, Laron Z. The correlation between being born short at term and height, weight and blood pressure at age 17. (Abstract #P2-d1-379). Horm Res. 2008;70(Suppl. 1):114.  Farfel A, Derazne E, Tzur D, Linder N, Laron Ζ. Female neonates born long or overweight for gestational age become tall and overweight adults (Abstract P2-d2- 651). Horm Res Paediatr. 2010;74(3):194-195. – Please contact the medical library for a copy.

 Farfel A, Derazne E, Ztur D, Linder N, Laron Ζ. Female neonates born long or overweight for gestational age become tall and overweight adults (Abstract). Annual Meeting of the Israeli Clinical Pediatric Society. 2010;Abstract B:33. – Please contact the medical library for a copy.  Feiman G, Flexer Z, Karp M. Fiber supplemented meals in insulin dependent juvenile diabetics. Harefuah. 1980;108:204-205. – Please contact the medical library for a copy.  Feinberg MS, Scheinowitz M, Laron Z. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age. Am Heart J. 2003;145(3):549-553. doi:10.1067/mhj.2003.175  Feinberg MS, Scheinowitz M, Laron Z. Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome). Am J Cardiol. 2000;85(2):209-213. doi:10.1016/s0002-9149(99)00642-6– Please contact the medical library for a copy.  Feinberg MS, Scheinowitz M, Z.Laron. Cardiac dimension and function in treated patients with isolated and multiple pituitary growth hormone deficiency (Abstract P4). MedFair, Research Fair. 2001;Abstract P:298. – Please contact the medical library for a copy.  Fenning S, Laron Z. At what stage of childhood obesity should the psychosocial team intervene? Pediatr Endocrinol Rev. 2007;4(3):184-185. – Please contact the medical library for a copy.  Ferrandez A, Mengual J, Bastaros JC, Gonzalvo N, Laron Z, Silbergeld A. Nanismo con valores elevados de GH y no generacion de somatomedina tras hGH (syndrome de Laron) estudio clinico bioquimico de ocho casos. An Esp Pediat. 1985;22(2):113-122. – Please contact the medical library for a copy.  Fichera G, Arpi ML, Squatrito S, Purrello F, Ashkenazi I, Laron Z. Seasonality of month of birth of children (0-14 years old) with type 1 diabetes mellitus in the District of Catania, Sicily. J Pediatr Endocrinol Metab. 2001;14(1):95-96. doi:10.1515/jpem.2001.14.1.95– Please contact the medical library for a copy.  Fisher DA, Laron Z. The early history of pediatric - Endocrinology. Pediatric endocrinology reviews : PER. 2003;1 Suppl 1(SUPPL. 1):65-91. – Please contact the medical library for a copy.  Flatau E, Josefsberg Z, Reisner SH, Bialik O, Laron Z. Penile size in the newborn infant. J Pediatr. 1975;87(4):663-664. doi:10.1016/S0022-3476(75)80877-8. – Please contact the medical library for a copy.  Flechner I, Muntefering H, Smadja Y, Laron Z. Immunomodulation of streptozotocin- induced diabetes in mice by a lipopolysaccharide. Diabetes Research. 1984;1(4):231- 232. – Please contact the medical library for a copy.  Flechner I, Muntefering H, Smadja Y, Laron Z. Polyclonal activation and streptozotocin-induced diabetes in mice. In: Lessons from Animal Diabetes. ; 1984:304-307. – Please contact the medical library for a copy.  Flexer Z, Faiman G, Beith-Halachmi N, Karp M, Galatzer A, Laron Z. Knowledge on nutrition of juvenile diabetics. In: Nutrition and the Diabetic Child. Pediatric & Adolescent Endocrinology Vol. 7. ; 1979:177-180. – Please contact the medical library for a copy.  Frankel JJ, Laron Z. Psychological aspects of pituitary insufficiency in children and adolescents with special reference to growth hormone. Israel journal of medical sciences. 1968;4(5):953-961. – Please contact the medical library for a copy.  Frenkel J, Gil-Ad I, Klinger B, Deghenghi R, Laron Z. Intranasal administration of hexarelin, a potent GH releasing peptide. European Journal of Endocrinology. 1994;130(Suppl. 2):190. – Please contact the medical library for a copy.  Frenkel J, Silbergeld A, Deghenghi R, Laron Z. Short term effect of intranasal administration of hexarelin--a synthetic growth hormone-releasing peptide. Preliminary communication. J Pediatr Endocrinol Metab. 1995;8(1):43-45. doi:10.1515/jpem.1995.8.1.43– Please contact the medical library for a copy.  Frish M, Galatzer A, Laron Z. {Child-parent attitudes towards diabetes}.‏ Psychological Aspects of Balance of Diabetes in Pediatric and Adolescent Endocrinology. 1977;3:55-58. – Please contact the medical library for a copy.  Gafny M, Silbergeld A, Klinger B, Wasserman M, Laron Z. Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin. Clin Endocrinol (Oxf). 1994;41(2):169-175. doi:10.1111/j.1365-2265.1994.tb02526.x. – Please contact the medical library for a copy.  Gafny M, Silbergeld A, Wasserman M, Klinger B, Laron Z. Insulin not IGF-I or GH regulates sex hormone binding globulin (SHBG) levels. European Journal of Endocrinology. 1994;130(Suppl. 2):205. – Please contact the medical library for a copy.  Gafny M, Silbergeld A, Wasserman M, Klinger B, Laron Z. Insulin rather than IGF-I or GH regulates sex hormone binding globulin (SHBG) levels. Endocrinology and Metabolism, Supplement. 1994;1-Suppl.(Abstract P.138):69. – Please contact the medical library for a copy.  Galatzer A, Amir S, Gil R, Karp M, Laron Z. Crisis intervention program in newly diagnosed diabetic children. Diabetes Care. 1982;5(4):414-419. doi:10.2337/diacare.5.4.414. – Please contact the medical library for a copy.  Galatzer A, Aran O, Nagelberg N, Rubitzek J, Laron Z. Cognitive & Psychosocial Functioning of Young Adults with Laron Syndrome. In: Z.Laron, Parks JS, eds. Lessons from Laron Syndrome (LS), 1966-1992, Pediat. Adolesc. Endocrinol. Karger; 1993:53- 60. – Please contact the medical library for a copy.  Galatzer A, Aran O, Nagelberg N, Rubitzek J, Laron Z. Cognitive and psychosocial functioning of young adults with Laron Syndrome. In: Growth,Stature and Adaption. Behavioral, Social, and Cognitive Aspects of Growth Delay. ; 1994:241. – Please contact the medical library for a copy.  Galatzer A, Beit-Halachmi N, Topper E, Flexer Z, Gill R, Laron Z. An attempt to predict diabetes control by psychosocial variables. In: Nutrition and the Diabetic Child. Pediatric & Adolescent Endocrinology Vol. 7. ; 1979:170-176. – Please contact the medical library for a copy.  Galatzer A, Beth-Halachmi N, Kauli R, Laron Z. Intellectual function of girls with precocious puberty. Pediatrics. 1984;74(2):246-249.  Galatzer A, Kaufman V, Laron Z. Psychological aspects of delayed puberty in boys. In: Recent Progress in Pediatric Endocrinology, Proc. of the Serono Foundation Symposia, No. 12. ; 1977:153-155. – Please contact the medical library for a copy.  Galatzer A, Laron Z. Psychological evaluation of newly diagnosed diabetics and their families. In: Psychological Aspects of Diabetes in Children and Adolescents. Pediatric & Adolescent Endocrinology Vol. 10. ; 1982:51-59. – Please contact the medical library for a copy.  Galatzer A, Laron Z. Psychological factors associated with the use of subcutaneous insulin infusion pump (SCII) and self blood glucose monitoring (SBGM) during pregnancy. In: Carbohydrate Metabolism in Pregnancy and the Newborn. ; 1984:68- 73. – Please contact the medical library for a copy.  Galatzer A, Rosenblith E, Laron Z. Psychological and rehabilitation aspects of short stature and delayed puberty. In: Auxology: Human Growth in Health and Disorder. Proc. Serono Symp., Vol. 13. ; 1978:303-311. – Please contact the medical library for a copy.  Galazer A. Psychosocial aspects of short stature. Modern Endocrinology & Diabetes. 1995;3:125-129. – Please contact the medical library for a copy.  Galli-Tsinopoulou A, Nousia-Arvanitakis S, Tsinopoulos I, Bechlivanides C, Shevah O, Laron Z. Laron syndrome. First report from Greece. Hormones (Athens). 2003;2(2):120-124.  Garty B, R. K. Sexual development in the Prader-Labhart-Willi syndrome. (Editorial). Harefuah. 1982;102:28-29. – Please contact the medical library for a copy.  Garty B, Shuper A, Mimouni M, Varsano I, Kauli R. Primary gonadal failure and precocious adrenarche in a boy with Prader-Labhart-Willi syndrome. Eur J Pediatr. 1982;139(3):201-203. doi:10.1007/bf01377358. – Please contact the medical library for a copy.  Garty BZ, Kauli R, Benari J, Lubin E, Nitzan M, Laron Z. Hepatitis Associated With Propylthiouracil Treatment. Drug Intelligence & Clinical Pharmacy. 1985;19(10):740- 742. – Please contact the medical library for a copy.  Garty BZ, Levy I, Laron Z. Hypothalamic hypopituitarism following shigella encephalopathy. Israel Medical Association Journal. 1999;1(1):50-51.  Garty B-Z. Myopathy associated with ketoconazole treatment. Arch Pediatr Adolesc Med. 1991;145(9):970. doi:10.1001/archpedi.1991.02160090020010. – Please contact the medical library for a copy.  Gdansky E, Diamant YZ, Laron Z, Silbergeld A, Kaplan B, Eshet R. Increased number of IGF-I receptors on erythrocytes of women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 1997;47(2):185-190. doi:10.1046/j.1365-2265.1997.2251043.x. – Please contact the medical library for a copy.  German J, Bloom D, Passarge E, et al. Bloom’s syndrome. VI. The disorder in Israel and an estimation of the gene frequency in the Ashkenazim. Am J Hum Genet. 1977;29(6):553-562.  Gil Ad I, Weizman A, Silbergeld A, et al. Differential effect of insulin-like growth factor-1 and growth hormone on hypothalamic regulation of growth hormone secretion in the rat. J Endocrinol Invest. 1996;19(8):542-547. – Please contact the medical library for a copy.  Gil R, Beit-Halachmi N, Galatzer A, Laron Z. A study of courting and marriage in young diabetics. In: Recent Progress in Medico-Social Problems in Juvenile Diabetics. Pediatric & Adolescent Endocrinology Vol. 11. ; 1983:11-15. – Please contact the medical library for a copy.  Gil R, Galatzer A, Beit-halachmi N, Topper E, Flexer Z, Laron Z. Family dynamics of eating habits in young diabetics. In: Nutrition and the Diabetic Child. Pediatric & Adolescent Endocrinology Vol. 7. ; 1979:140-146. – Please contact the medical library for a copy.  Gil R, Galatzer A, Karp M, et al. Attitude of nonaffected and affected siblings to juvenile diabetes: a retrospective study in multidiabetic families. Discussion. Pediatric and adolescent endocrinology. 1993;23:171-174. – Please contact the medical library for a copy.  Gil R, Galatzer A. Attitude to juvenile diabetes before and after onset of IDDM in second sibling in family: A retrospective study. J Pediat Endocrinol. 1991;4(3):Abstract 48. – Please contact the medical library for a copy.  Gil-Ad I, Bar-Yoseph J, Smadja Y, Zohar M, Laron Z. Effect of clonidine on plasma beta-endorphin, cortisol and growth hormone secretion in opiate-addicted subjects. Isr J Med Sci. 1985;21(7):601-604. – Please contact the medical library for a copy.  Gil-Ad I, Dickerman Z, Weizman R, Weizman A, Tyano S, Laron Z. Abnormal growth hormone response to LRH and TRH in male adolescent schizophrenic boys. Amer J Psychiat. 1981;138(March):357-360. – Please contact the medical library for a copy.  Gil-Ad I, Fridberg G, Flex L, et al. Evidence for elevated circulatory somatostatin levels in anorexia nervosa: Effect of mixed meal. J Endocrinology Investigation. 1993;16(Suppl. 1):Abstract S46. – Please contact the medical library for a copy.  Gil-Ad I, Gurewitz R, Marcovici O, Rosenfeld J, Laron Z. Effect of aging on human plasma growth hormone response to clonidine. Mech Ageing Dev. 1984;27(1):97- 100. doi:10.1016/0047-6374(84)90086-1. – Please contact the medical library for a copy.  Gil-Ad I, Laron Z, Koch Y. Effect of acute and chronic administration of clonidine on hypothalamic content of growth hormone-releasing hormone and somatostatin in the rat. J Endocrinol. 1991;131(3):381-385. doi:10.1677/joe.0.1310381. – Please contact the medical library for a copy.  Gil-Ad I, Laron Z, Muller E E, Laron Z. Effect of acute and chronic administration of IGF-I and growth hormone (GH) on hypothalamic regulation of GH secretion in the rat. Abstract 32. J Endocrinol Invest. 1992;15(supp. 4)– Please contact the medical library for a copy.  Gil-Ad I, Topper E, Bar-Yoseph J, Mamet R, Laron Z. Comparison of the effect of insulin hypoglycemia and clonidine on secretion of growth hormone, cortisol and beta-endorphin in children and adolescents. Isr J Med Sci. 1985;21(11):912-914. – Please contact the medical library for a copy.  Gil-Ad I, Topper E, Laron Z. Oral clonidine as a growth hormone stimulation test. Lancet. 1979;2(8137):278-279. doi:10.1016/s0140-6736(79)90293-9. – Please contact the medical library for a copy.  Gil-Ad I, Zeevi B, Shohat-zabarski R, et al. Changes in atrial natriuretic peptide (ANP), cortisol and aldosterone levels in children with congenital heart defects undergoing interventional cardiac catheterizations. In: Annual Meeting of the Israel Endocrine Society. ; 1993:45. – Please contact the medical library for a copy.  Ginsberg S, Laron Z, Bed MA, Vaisman N. The obesity of patients with Laron Syndrome is not associated with excessive nutritional intake. Obes Res Clin Pract. 2009;3(1):1-52. doi:10.1016/j.orcp.2008.11.001  Glikson M, Gil-Ad I, Galun E, et al. Acromegaly due to ectopic growth hormone- releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli. Acta Endocrinol. 1991;125(4):366-371. – Please contact the medical library for a copy.  Global regulations on diabetic treated with insulin and their operation of commercial motor vehicles. DiaMond Project Group on Social Issues. BMJ. 1993;307(6898):250-253. doi:10.1136/bmj.307.6898.250  Green A, Gale EA, Patterson CC. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet. 1992;339(8798):905-909. doi:10.1016/0140-6736(92)90938-y.  Green A, Laron Z, Gordon O. The epidemology of IDDM in Europe: What can we learn? (Abstract A21). Diabetes in the Young. 1994;30(2):PLI. – Please contact the medical library for a copy.  Gurewitz R, Cader Y, Kauli R, Keret R, Laron Z. Comparison between growth hormone secretion during sleep and provocative tests in children and adolescents. Harefuah. 1980;108:53-56. – Please contact the medical library for a copy.  Gurewitz R, Dickerman Z, Peleg S, Keret R, Gidali A, Laron Z. Dynamics of basal pituitary gonadotropin secretion and responsiveness to LRH following estradiol benzoate in normal girls. Horm Res. 1982;16(3):174-181. doi:10.1159/000179499. – Please contact the medical library for a copy.  Har-Zahav L, Kauli R, Pertzelan A, Laron Z. The treatment of precocious puberty with cyproterone acetate. Harefuah. 1978;94:216-219. – Please contact the medical library for a copy.  Heilstrom A, Carlsson B, Albertsson-wikland K, et al. Reduced retinal vascularisation in patients with defects in the GH receptor or IGF-I receptor genes. Pediatr Res. 2001;49(76A):P1-451. – Please contact the medical library for a copy.  Hellstrom A. IGF-I Is Critical for Normal Vascularization of the Human Retina. Journal of Clinical Endocrinology & Metabolism. 2002;87(7):3413-3416. doi:10.1210/jc.87.7.3413  Hering R, Gilad I, Laron Z, Kuritzky A. Effect of sodium valproate on the secretion of prolactin, cortisol and growth hormone in migraine patients. Cephalalgia. 1992;12(4):257-258. doi:10.1046/j.1468-2982.1992.1204257.x. – Please contact the medical library for a copy.  Hershkovitz I, Kornreich L, Laron Z. Comparative skeletal features between Homo floresiensis and patients with primary growth hormone insensitivity (Laron Syndrome). Am J Phys Anthropol. 2007;134(2):198-208. doi:10.1002/ajpa.20655. – Please contact the medical library for a copy.  Hirsch M, Josefsberg Z, Schoenfeld A, et al. Congenital hereditary hypothyroidism-- prenatal diagnosis and treatment. Prenat Diagn. 1990;10(8):491-496. doi:10.1002/pd.1970100803. – Please contact the medical library for a copy.  HLA, DQ and TCR beta chain polymorphisms in jewish multiple case diabetes families. Hum Immunol. 1990;29:70. doi:10.1016/0198-8859(90)90251-J. – Please contact the medical library for a copy.  Hochberg Y, Marom I, Keret R, Peleg S. On improved calibrations of unknowns in a system of quality-controlled assays. Biometrics. 1983;39(1):97-107. – Please contact the medical library for a copy.  Hochberg Z, Dickerman Z, Kaufman H, Laron Z. Evaluation of the renin-aldosterone system during hypo- and hyperglycemia in children and adolescents. Horm Res. 1980;12(1):16-21. doi:10.1159/000179101. – Please contact the medical library for a copy.  Hochman IH, Laron Z. The effect of methandrostenolone on pituitary growth hormone secretion. Horm Metab Res. 1970;2(5):260-264. doi:10.1055/s-0028- 1095085. – Please contact the medical library for a copy.  Hummel M, Lewy H, Ziegler AG, Ashkenazi I, Laron Z. Pattern of month of birth in diabetic and non-diabetic adults. Isr Med Assoc J. 2002;4(1):74. – Please contact the medical library for a copy.  Hummel M, Ziegler AG, Lewy H, Ashkenazi I, Laron Z. IAA/GAD-positive offspring of diabetic parents have a different seasonality in month of birth than antibody- negative offspring. Diabetes Care. 2001;24(11):2001.  Ilicki A, Prager Lewin R, Kauli R, Kaufman H, Schachter A, Laron Z. Premature thelarche--natural history and sex hormone secretion in 68 girls. Acta Paediatr Scand. 1984;73(6):756-762. doi:10.1111/j.1651-2227.1984.tb17771.x. – Please contact the medical library for a copy.  International analysis of insulin-dependent diabetes mellitus mortality: a preventable mortality perspective. The Diabetes Epidemiology Research International (DERI) Study. Am J Epidemiol. 1995;142(6):612-618. – Please contact the medical library for a copy.  J. M, Lewy H, Figal J, Norris J, Rewers M, Laron Z. Seasonality of Birth in Children with Type 1 Diabetes in Colorado. Diabetes. 2002;51:A535-A536. – Please contact the medical library for a copy.  Jacobs LS, Sneid DS, Garland JT, Laron Z, Daughaday WH. Receptor-active growth hormone in Laron dwarfism. J Clin Endocrinol Metab. 1976;42(2):403-406. doi:10.1210/jcem-42-2-403. – Please contact the medical library for a copy.  Jorge AAL PE Meyer D, Laron Z, Guevara-Aguirre J, Cassorla FG, Damiani D, Lins TS, Shevah O, Hwa V, Rosenbloom AL, Rosenfeld RG, Arnhold IJP. The founder effect of E180 splice mutation in growth hormone receptor (GHR) gene causing Laron syndrome in Israel, Ecuador, Brazil and Chile: a witness of Jewish exodus from the Iberian Peninsula to the New World. (Abstract P1-659). ENDO 2010. 2010:45. – Please contact the medical library for a copy.  Josefsberg Z, Aran O, Laron Z. Safety of pituitary growth hormone extracted with acetone/acetic acid. Lancet. 1994;344(8915):130. doi:10.1016/S0140- 6736(94)91317-X  Josefsberg Z, Gh F, Sa R. Progression of microalbuminuria in non-insulin dependent diabetics. Annual Meetings of the ADA and IDF, USA Diabetes. 1991;40(380A):1517. – Please contact the medical library for a copy.  Josefsberg Z, Laron Z, Kauli R, et al. Plasma insulin response to arginine stimulation in children and adolescents with constitutional short stature according to sex, age, sexual development and skinfold thickness. Diabete Metab. 1978;4(2):103-107. – Please contact the medical library for a copy.  Josefsberg Ζ, Hwang DL, Lev-Ran A. Serum Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF) in Diabetic Patients Below Age 18. Journal of Pediatric Endocrinology and Metabolism. 1992;5(4). doi:10.1515/JPEM.1992.5.4.249. – Please contact the medical library for a copy.  Kalter-Leibovici O, Laron Z. Vascular complications of childhood diabetes mellitus. Current Opinion in Pediatrics. 1992;4(4):685-694. – Please contact the medical library for a copy.  Kalter-Leibovici O, Leibovici L, Loya N, et al. The development and progression of diabetic retinopathy in type I diabetic patients: a cohort study. Diabet Med. 1997;14(10):858-866. doi:10.1002/(SICI)1096-9136(199710)14:10<858::AID- DIA471>3.0.CO;2-V.  Kalter-Leibovichi O, Leibovichi L , Loya N, Kremer I, Segal R, Karp M, Laron Z. The development and progression of diabetic retinopathy in IDDM patients. Diabetes in the Young (Abstracts issue). 1992; A7. – Please contact the medical library for a copy.  Kalter-leibovici O, Leibovici L, Loya N, Kremer I, Karp M, Laron Z. Relation of puberty to development of nonproliferative retinopathy in young IDDM patients. Pediatric and adolescent endocrinology. 1992;22:147-155. – Please contact the medical library for a copy.  Kalter-Leibovici O, Van Dyk DJ, Leibovici L, et al. Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes. 1991;40(2):204-210. doi:10.2337/diab.40.2.204. – Please contact the medical library for a copy.  Kalter-leibovici O. Diabetic neuropathy. In: An Update on Child Diabetes and Short Stature. ; 1993:87-93. – Please contact the medical library for a copy.  Kanety H, Hemi R, Ginsberg S, et al. Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur J Endocrinol. 2009;161(6):837-844. doi:10.1530/EJE-09-0419  Kanety H, Karasik A, Klinger B, Silbergeld A, Laron Z. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity (Abstract). In: Annual Meeting of the Israel Endocrine Society. ; 1993:14. – Please contact the medical library for a copy.  Kanety H, Karasik A, Klinger B, Silbergeld A, Laron Z. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. Acta Endocrinologica. 1993;128(2):144-149. – Please contact the medical library for a copy.  Kanety H, Silbergeld A, Klinger B, Karasik A, Baxter RC, Laron Z. Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. Eur J Endocrinol. 1997;137(6):626-630. doi:10.1530/eje.0.1370626. – Please contact the medical library for a copy.  Kaplan M, Kauli R, Lubin E. {Etopic thyroid gland — Clinical study of 30 children and review.}. J Pediat. 1978;92(2):205-209. – Please contact the medical library for a copy.  Kaplan M, Kauli R, Raviv U, Lubin E, Laron Z. Hypothyroidism due to ectopy in siblings. Am J Dis Child. 1977;131(11):1264-1265. doi:10.1001/archpedi.1977.02120240082018. – Please contact the medical library for a copy.  Karnieli E. Insulin resistance in GH-deficient adult patients treated with growth hormone. Growth hormone replacement therapy in adults .1993: 41-49. – Please contact the medical library for a copy.

 Karp M, Faiman G, Flexer Z. Blood glucose and clinical response to fiber- supplemented meals in young insulin-dependent diabetics. Nutrition and the diabetic child, 4th International Beilinson Symposium, Herzlia, 1978 ; volume editors, Zvi Laron, Moshe Karp. 1979:77-82. – Please contact the medical library for a copy.  Karp M, Kott E, Shapira M, et al. Unusual association of insulin-dependent diabetes mellitus with congenital myasthenia gravis and autoimmune thyroid disease. Isr J Med Sci. 1984;20(11):1078-1081. – Please contact the medical library for a copy.  Karp M, Laron Z, Doron M. Insulin response to intravenous glucagon in children with familial constitutional short stature. Arch Dis Child. 1975;50(10):805-808. doi:10.1136/adc.50.10.805. – Please contact the medical library for a copy.  Karp M, Laron Z, Doron M. Insulin secretion in children with constitutional familial short stature. J Pediatr. 1973;83(2):241-246. doi:10.1016/s0022-3476(73)80483-4. – Please contact the medical library for a copy.  Karp M, Laron Z, Pertzelan A. Glucose tolerance and insulin secretion in parents and children with familial dwarfism and high plasma immunoreactive growth hormone (IR-HGH) and familial isolated growth hormone deficiency. Horm Metab Res. 1972;4(4):284-288. doi:10.1055/s-0028-1094068  Karp M, Laron Z. Efficacia nell’approcio di gruppo multidisciplinare nella terapia del diabete. ??? 1983:225-233. – Please contact the medical library for a copy.  Karp M. Education of diabetic children and adolescents. Diabetes Reviews. 1993:10- 14. – Please contact the medical library for a copy.  Karp M. Insulin in small doses in the treatment of diabetic ketoacidosis. (Editorial). Harefuah. 1978;95:37-38. – Please contact the medical library for a copy.  Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia. 1993;36(10):883-892. doi:10.1007/bf02374468. – Please contact the medical library for a copy.  Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000;23(10):1516-1526. doi:10.2337/diacare.23.10.1516  Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Hormone Research. 1997;47(2):54-61. – Please contact the medical library for a copy.  Kauli R, Galatzer A, Laron Z. Treatment of Diabetes insipidus in Children and Adolescents. In: Czernichow P, Robinson AG, eds. Diabetes Insipidus in Man: International Symposium, Paris, January 1984. Vol 13. Frontiers of hormone research. S. Karger AG; 1985:304-313. doi:10.1159/000410115. – Please contact the medical library for a copy.  Kauli R, Kornreich L, Lazar L, Laron Z. Final height (FHt) of girls with central precocious puberty (CPP): untreated and treated with cyproterone acetate (CyA) or with GnRH Analogue (GnRHA). Gynecol Endocrinol. 1993;(Suppl. 2):Abstract 129, pg. 75. – Please contact the medical library for a copy.  Kauli R, Korenreich L, Pertzelan A, Laron Z. The dynamics of adrenarche in girls with central precocious puberty (CPP) during gonadotropin (Gn) suppressive therapy with the GnRH analog D-TRP-6-LHRH. Hormone Res. 1992;38(supp.4):34. – Please contact the medical library for a copy.  Kauli R, Laron Z. Pubertal development in girls with sexual precocity after discontinuation of treatment with cyproterone acetate. Helvetica Paediatrica Acta. 1980;35(2):149-154. – Please contact the medical library for a copy.  Kauli R, Lazar L, Kornreich L, Galatzer A, Laron Z. Final height (FHt) of girls with central precocious puberty (CPP) - untreated as compared to treated with GnRH analog (GnRH-a) or with cyproterone acetate (CyA). (Abstract #273). Horm Res. 1995;44(Suppl. 1):69. – Please contact the medical library for a copy.  Kauli R, Lazar L, Kornreich L, Galatzer A, Laron Z. Final height (FHt) of girls with early and fast puberty - untreated versus treated with GnRH analogue (GnRHa). (Abstract #437). Horm Res. 1996;46(Suppl. 2):110. – Please contact the medical library for a copy.  Kauli R, Pertzelan A, Ben-Zeev Z, et al. Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience. Clin Endocrinol (Oxf). 1984;20(4):377-387. doi:10.1111/j.1365-2265.1984.tb03433.x. – Please contact the medical library for a copy.  Kauli R, Pertzelan A, Prager-Lewin R, Maimon Z, Ovadia J, Laron Z. XY gonadal dysgenesis associated with hGH and gonadotrophin deficiencies. Clin Genet. 1979;15(5):369-376. doi:10.1111/j.1399-0004.1979.tb01768.x. – Please contact the medical library for a copy.  Kauli R, Prager-lewin R, Kaufman H, Laron Z. Gonadal function in Bloom’s syndrome. Clin Endocrinol (Oxf). 1977;6(4):285-289. doi:10.1111/j.1365-2265.1977.tb02013.x. – Please contact the medical library for a copy.  Kauli R, Prager-Lewin R, Keret R, Laron Z. The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate. Eur J Pediatr. 1977;125(3):205-212. doi:10.1007/bf00480598. – Please contact the medical library for a copy.  Kauli R, Prager-Lewin R, Laron Z. Pubertal development in the Prader-Labhart-Willi syndrome. Acta Paediatr Scand. 1978;67(6):763-767. doi:10.1111/j.1651- 2227.1978.tb16258.x. – Please contact the medical library for a copy.

 Kauli R, Schoenfeld A, Ovadia Y, Math S, Assa S, Laron Z. Delayed puberty and hypoplastic uterus associated with hyperprolactinemia: successful treatment with bromocriptine. Horm Res. 1985;22(1-2):68-73. doi:10.1159/000180074. – Please contact the medical library for a copy.  Kauli R, Zaizov R, Lazar L, et al. Delayed growth and puberty in patients with Gaucher disease type 1: Natural history and effect of splenectomy and/or enzyme replacement therapy. Israel Medical Association Journal. 2000;2(2):158-163.  Kauschansky A, Cohen HA, Varsano I, Laron Z, Frydman M. Familial isolated growth- hormone deficiency with advanced sexual maturation. Am J Dis Child. 1993;147(2):170-173. doi:10.1001/archpedi.1993.02160260060023. – Please contact the medical library for a copy.  Kaushanski A, Laron Z. Growth pattern of boys with isolated gonadotropin deficiency. Isr J Med Sci. 1979;15(6):518-521. – Please contact the medical library for a copy.  Keret R, Ashkenazi IE, Wasserman M, et al. Two types of growth hormone rhythm in boys with constitutional short stature. Journal of Pediatric Endocrinology and Metabolism. 1996;9(6):599-607. – Please contact the medical library for a copy.  Keret R, Mathiash S, Brown M, Pertzelan A, Levy I, Laron Z. Correlation between plasma growth hormone and insulin and blood glucose concentrations in premature infants. Horm Res. 1976;7(6):313-318. doi:10.1159/000178745. – Please contact the medical library for a copy.  Keret R, Pertzelan A, Zeharia A, Zadik Z, Laron Z. Growth-Hormone (Hgh) Secretion and Turnover in 3 Patients With Laron-Type Dwarfism. Israel Journal of Medical Sciences. 1988;24(2):75-79. – Please contact the medical library for a copy.  Kida K, Mimura G, Ito T, Murakami K, Ashkenazi I, Laron Z. Incidence of Type 1 diabetes mellitus in children aged 0-14 in Japan, 1986-1990, including an analysis for seasonality of onset and month of birth: JDS study. The Data Committee for Childhood Diabetes of the Japan Diabetes Society (JDS). Diabet Med. 2000;17(1):59- 63. doi:10.1046/j.1464-5491.2000.00205.x  Kitagawa T, Fujita H, Hibi I, et al. A comparative study on the epidemiology of IDDM between japan, norway, israel and the united states. Pediatr Int. 1984;26(3):275- 281. doi:10.1111/j.1442-200X.1984.tb01825.x. – Please contact the medical library for a copy.  Kleine T, Merten B, Meier H, et al. Effect of normal and pathological sera of patients with low serum somatomedin levels on proteoglycan glycosaminoglycan biosynthesis in two types of cartilage. In: Biochimie Des Tissues Conionctifs Normaux et Pathologiques. ; 1980:173-175. – Please contact the medical library for a copy.

 Kleinhaus N, Arad J, Laron Z. {Silver Russell Syndrome — description of six children.}. Harefuah. 1983;105(10):297-302. – Please contact the medical library for a copy.  Klinger B, Anin Z, Flexer Z, Laron Z. IGF-1 treatment of adult patients with Laron Syndrome. In: Laron Z, Parks J S (eds.) Lessons from Laron syndrome (LS) 1966-1992. 1993;24:237-243.  Klinger B, Anin S, Laron Z. Long-term IGF-I therapy of children with Laron Syndrome (Abstract). In: Annual Meeting of the Israel Endocrine Society. ; 1993:13. – Please contact the medical library for a copy.  Klinger B, Anin S, Laron Z. Two-year treatment of Laron Syndrome children with IGF- I. Endocrinology and Metabolism, Supplement. 1994;1(B):16 (Abstract O.032). – Please contact the medical library for a copy.  Klinger B, Anin S, Laron Ζ. Hyperandrogenism induced by IGF-I administration to female patients with Laron syndrome. (Abstract #123). Horm Res. 1996;46(Suppl. 2):32. – Please contact the medical library for a copy.  Klinger B, Anin S, Lilos P, Pertzelan A, Laron Z. Effect of growth hormone treatment on linear growth in children with constitutional short stature and intrauterine growth retardation. In: Limb Lengthening: For Whom, When and How?. ; 1995:73- 78. – Please contact the medical library for a copy.  Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol (Oxf). 1998;48(1):81-87. doi:10.1046/j.1365- 2265.1998.00356.x  Klinger B, Avitzur Y, Laron Z. Changing pattern with age of glucose tolerance in patients with Laron Syndrome. Horm Res. 1994;41(Abstract 113):85. – Please contact the medical library for a copy.  Klinger B, Avizur B, Laron Z. Changing pattern with age of glucose tolerance in patients with Laron Syndrome. Diabetes in the Young (Abstracts issue). 1993;29(Abstract 11):37. – Please contact the medical library for a copy.  Klinger B, Erster B, Klipper-Aurbach Y, Gil-Ad I, Anin S, Laron Z. Acute Effects of IGF-1 in Patients with Laron Syndrome and Normal Subjects. In: Lessons from Laron Syndrome (LS) 1966-1992 : A Model of GH and IGF-1 Action and Interaction, Pediat. Adolesc. Endocrinol. ; 1993:221-225. – Please contact the medical library for a copy.  Klinger B, Garty M, Silbergeld A, Laron Z. Elimination characteristics of intravenously administered rIGF-I in Laron-type dwarfs. Dev Pharmacol Ther. 1990;15(3-4):196- 199. – Please contact the medical library for a copy.  Klinger B, Ionesco A, Anin S, Laron Z. Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects. Acta Endocrinol. 1992;127(6):515-519. doi:10.1530/acta.0.1270515. – Please contact the medical library for a copy.  Klinger B, Jensen LT, Silbergeld A, Laron Z. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome. Clin Endocrinol (Oxf). 1996;45(4):423-429. doi:10.1046/j.1365-2265.1996.7990809.x. – Please contact the medical library for a copy.  Klinger B, Laron Z. Renal function in Laron syndrome patients treated by insulin-like growth factor-I. Pediatr Nephrol. 1994;8(6):684-688. doi:10.1007/bf00869089. – Please contact the medical library for a copy.  Klinger B, Laron Z. Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab. 1995;8(3):149-158. doi:10.1515/jpem.1995.8.3.149. – Please contact the medical library for a copy.  Klinger B, Pinhas L, Blieden L, Laron Z. P-103. effect of gh treatment on cardiac functions in young adult gh deficient patients. Endocrinology and Metabolism, Supplement. 1997;4(A):75. – Please contact the medical library for a copy.  Klinger B, Silbergeld A, Deghenghi R, Frenkel J, Laron Z. Desensitization from long- term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children. Eur J Endocrinol. 1996;134(6):716-719. doi:10.1530/eje.0.1340716. – Please contact the medical library for a copy.  Klinger B, Silbergeld A, Eshet R, Laron Z. A Variant of Laron Syndrome With an Intracellular Defect. Response to IGF-I Treatment. Proceedings of the 75th Annual Meeting of the Endocrine Society. 1993;(Abstract 1318):380. – Please contact the medical library for a copy.  Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses. 1995;45(5):486-490. doi:10.1016/0306-9877(95)90228-7. – Please contact the medical library for a copy.  Klipper-Aurbach Y, Wasserman M, Weintraub N, et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with IDDM. J Pediat Endocrinol. 1991;4(3):Abstract 68 (15). – Please contact the medical library for a copy.  Konen O, Silbergeld A, Kornreich L, Laron Z. Hand size and growth in untreated and IGF-1 treated patients with Laron syndrome. (Abstract #P2-d1-374). Horm Res. 2008;70(Suppl. 1):112.  Konen O, Silbergeld A, Lilos P, Kornreich L, Laron Z. Hand size and growth in untreated and IGF-I treated patients with Laron syndrome. Journal of Pediatric Endocrinology and Metabolism. 2009;22(3):235-239. – Please contact the medical library for a copy.  Konfino R, Pertzelan A, Laron Z. Cephalometric measurements of familial dwarfism and high plasma immunoreactive growth hormone. Am J Orthod. 1975;68(2):196- 201. doi:10.1016/0002-9416(75)90208-0. – Please contact the medical library for a copy.  Kopchick JJ, Laron Z. Is the Laron mouse an accurate model of Laron syndrome? Mol Genet Metab. 1999;68(2):232-236. doi:10.1006/mgme.1999.2890. – Please contact the medical library for a copy.  Kornreich L, Horev G, Schwartz M, Karmazyn B, Laron Z. Imaging of the brain in patients with Laron Syndrome. MedFair, Research Fair. 2001;Abstract P:301. – Please contact the medical library for a copy.  Kornreich L, Horev G, Schwartz M, Karmazyn B, Z L. Laron Syndrome: A paradigm for the influence of growth hormone deficiency on the oropharynx and cervical spine. MedFair, Research Fair. 2001;Abstract P:302. – Please contact the medical library for a copy.  Kornreich L, Horev G, Schwarz M, Karmazyn B, Laron Z. Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity). Eur J Endocrinol. 2002;146(4):499-503. doi:10.1530/eje.0.1460499  Kornreich L, Horev G, Schwarz M, Karmazyn B, Laron Z. Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx. AJNR Am J Neuroradiol. 2002;23(4):625-631.  Kornreich L, Horev G, Schwarz M, Karmazyn B, Laron Z. Pituitary size in patients with Laron syndrome (primary GH insensitivity). Eur J Endocrinol. 2003;148(3):339-341. doi:10.1530/eje.0.1480339  Kornreich L, Konen O, Schwarz M, et al. Abnormalities of the axial and proximal appendicular skeleton in adults with Laron syndrome (growth hormone insensitivity). Skeletal Radiol. 2008;37(2):153-160. doi:10.1007/s00256-007-0402-7  Kornreich L, Konen O, Schwarz M, Horev G, Karmazyn B, Laron Z. Imaging features of Laron syndrome (primary growth hormone insensitivity). (Abstract #0205MS-e). Radiological Society of North America (RSNA), Abstract Book. 2004:711. – Please contact the medical library for a copy.  Kornreich L, Schwartz M, Konen O, Horev G, Laron Z. Skeletal findings in adult patients with Laron syndrome (primary GH insensitivity). (Abstract P1-519). Proceedings of the 86th Annual Meeting of The Endocrine Society. 2004:284. – Please contact the medical library for a copy.  Kraiem Z, Bowers CY, Sobel E, Laron Z. Growth hormone (GH)-releasing heptapeptide, but not GH-releasing hormone, inhibits thyrotropin-stimulated thyroid hormone secretion and cAMP formation in cultured human thyroid follicles. Eur J Endocrinol. 1995;133(1):117-120. doi:10.1530/eje.0.1330117. – Please contact the medical library for a copy.  Krassas GE, Laron Z. A questionnaire survey concerning the most favourable treatment for Graves’ disease in children and adolescents. Eur J Endocrinol. July 2004:155-156. doi:10.1530/eje.0.1510155.  Krassas GE, Tziomalos K, Pontikides N, Lewy H, Laron Z. Seasonality of month of birth of patients with Graves’ and Hashimoto’s diseases differ from that in the general population. Eur J Endocrinol. 2007;156(6):631-636. doi:10.1530/EJE-07-0015.  Kržišnik C, Grguric S, Cvijovic K, Laron Z. Longevity of the hypopituitary patients from the Island Krk: A follow-up study. Pediatric Endocrinology Reviews. 2010;7(4):357- 362. – Please contact the medical library for a copy.  Krzisnik C, Kolacio Z, Battelino T, Brown M, Parks JS, Laron Z. The ’little people’ of the island of Krk - Revisited. Etiology of hypopituitarism revealed. Journal of Endocrine Genetics. 1999;1(1):9-19. – Please contact the medical library for a copy.  Laron, Z., 1966. Effects of hormones on the microstructure of bone, with special emphasis on cortisone.In: Somatic Growth of the Child. Leiden, Netherlands, HE Stenfert Kroese NV, p.63. . – Please contact the medical library for a copy.  Laron Z. Insulin as a growth promoting hormone. In: Collu R et al. Pediatric Endocrinology. New York:Raven press. Pp. 149-165. – Please contact the medical library for a copy.  Laron Z. Nicotinamide: yes or no? diabetes, prevention and therapy. 1992;6(18). – Please contact the medical library for a copy.  Laron Z. Psychological factors in diabetes mellitus. Amer. J. Dis. Child. 1982; 134(10):1004. – Please contact the medical library for a copy.  Laron Z. et al. Laron type dwarfism and growth hormone gene deletion. In: Genetic Diversity Among Jews: Diseases And Markers At The Dna Level. 1st ed. (Bonnietamir B, Adam A, eds.). New York: Oxford University Press; 1992:248-258. – Please contact the medical library for a copy.  Laron Z LH. Are childhood autoimmune diseases including diabetes caused by a common perinatal environmental trigger? (Abstr, #2774-PO). Diabetes. 2008;57(Suppl. 1):A747. – Please contact the medical library for a copy.  Laron Z, Amir S, Galatzer A, Gil R, Blum J, Mimoumi M. Vorteile eines ambulanten multidisziplinären Behandlungsprogramms für diabetische Kinder. In: Ambulante Langzeitbehandlung Diabetischer Kinder Und Jun- Gendlicher. ; 1977:63-73. – Please contact the medical library for a copy.  Laron Z, Amir S, Gil R. Psychological aspects of diabetes in children and adolescents. Rivista Italiana di Pediatria. 1981;7(6):685-690. – Please contact the medical library for a copy.  Laron Z, Anin S, Klinger B. Long-term IGF-1 treatment of children with Laron syndrome. PEDIATRIC AND ADOLESCENT ENDOCRINOLOGY. 1993;24:226-236. – Please contact the medical library for a copy.  Laron Z, Anin S, Klipper-Aurbach Y, Klinger B. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet. 1992;339(8804):1258-1261. doi:10.1016/0140-6736(92)91594-x. – Please contact the medical library for a copy.  Laron Z, Arad I. Standards for upper/lower body segment ratio (sitting height/subischial leg length) from birth to 18 years in girls and boys. In: Acta Medica Auxologica Proceedings of the 1st International Congress of Auxology, Rome, Italy. Rome, Italy; 1977:159-164. – Please contact the medical library for a copy.  Laron Z, Ashkenazi I, Casu A, Songini M. Seasonality of birth of Sardinian children and young adults with Type 1 Diabetes (1989-1998). MedFair, Research Fair. 2001;Abstract P:303. – Please contact the medical library for a copy.  Laron Z, Ashkenazi I. Seasonality of month of birth of children with Type I diabetes (DM) is different from that in the general population. (Abstract # 115). J Pediatr Endocrinol Metab. 2000;12(Suppl 4):1238. – Please contact the medical library for a copy.  Laron Z, Assa S, Levinger Z, Karp M. A longitudinal study of islet cell antibodies in newly diagnosed diabetic children and adolescents (abstract). 7th Annual Meeting of the International Study Group on Diabetes in Children and Adolescents (ISGD),. 1982;Belletin 6(7). – Please contact the medical library for a copy.  Laron Z, Assa S, Menache R. Metabolic activity of individual electrophoretic fractions of human growth hormone1. The Journal of Clinical Endocrinology & Metabolism. 1963;23(3):315-317. doi:10.1210/jcem-23-3-315. – Please contact the medical library for a copy.  Laron Z, Avitsur Y, Klinger B. EFFECT OF GROWTH HORMONE (GH) AND INSULIN-LIKE GROWTH FACTOR-I (IGF-I) ON CARBOHYDRATE (CHO) METABOLISM. J PEDIAT ENDOCRINOL Metab. 1997;(Suppl. 1). – Please contact the medical library for a copy.  Laron Z, Avitzur Y, Klinger B. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. In: Progress on Childhood Diabetes Including Recent Progress on Growth Hormone - Editoriale Bios. ; 1997:139. – Please contact the medical library for a copy.  Laron Z, Avitzur Y, Klinger B. Effect of IFG-1 carbohydrate and fat metabolism. Acta Diabetologica Romana. 1994;20:116. – Please contact the medical library for a copy.  Laron Z, Avitzur Y, Klinger B. Glucose intolerance in primary chronic IGF-I deprivation (Laron Syndrome) effect of IGF-I treatment (Abstract A55). Diabetes in the Young. 1994;30(2):013. – Please contact the medical library for a copy.  Laron Z, Avitzur Y, Klinger B. Insulin resistance in Laron syndrome (primary insulin- like growth factor-I (IGF-I) deficiency) and effect of IGF-I replacement therapy. Journal of Pediatric Endocrinology and Metabolism. 1997;10(SUPPL. 1):105-115. – Please contact the medical library for a copy.  Laron Z, Aviv T. 78. Growth hormone and insulin-like growth factor-I: Effects on the brain. In: Hormones, Brain and Behavior, 2nd Edition. 2nd ed. ; 2009:2449-2471. – Please contact the medical library for a copy.  Laron Z, Ben-Amitai D, Lurie R. Impaired hair growth and structural defects in patients with laron syndrome (Primary IGF-I Deficiency). Pediatr Res. 2001;49(76A):P1-449. – Please contact the medical library for a copy.  Laron Z, Bidlingmaier M, Strasburger CJ. Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins. Pediatric Endocrinology Reviews. 2007;5(SUPPL. 1):555-569. – Please contact the medical library for a copy.  Laron Z, Bisker O, Kauli R. P15 Long-term administration of hGH or IGF-I increase body adiposity and serum cholesterol. Growth Horm IGF Res. 2010;20:S44-S45. doi:10.1016/S1096-6374(10)70115-5  Laron Z, Blum W, Chatelain P, et al. Classification of growth hormone insensitivity syndrome. Journal of Pediatrics. 1993;122(2):241. – Please contact the medical library for a copy.  Laron Z, Bowers CY, Hirsch D, et al. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Acta Endocrinologica. 1993;129(5):424-426. – Please contact the medical library for a copy.  Laron Z, Butenandt O. Bestimmung der wachstumshormonsekretion im kindersalter. Der Kinderarzt. 1982;13:1842. – Please contact the medical library for a copy.  Laron Z, Butenandt O. Conclusions of an international workshop on evaluation of growth hormone secretion (Physiology and clinical application). Eur J Pediatr. 1982;139(1):3-3. doi:10.1007/BF00442068. – Please contact the medical library for a copy.  Laron Z, Butenandt O. Optimum use of growth hormone in children. Drugs. 1991;42(1):1-8. doi:10.2165/00003495-199142010-00001. – Please contact the medical library for a copy.  Laron Z, Butenandt O. The young adult growth hormone deficient patients in whom treatment has been stopped at the end of puberty. In: Growth Hormone Replacement Therapy in Adults : Pros and Cons. ; 1993:21-30. – Please contact the medical library for a copy.  Laron Z, Canlas BD, Crawford JD. The action of cortisone on the teeth of rachitic rats. AMA archives of pathology. 1956;61(2):177-180. – Please contact the medical library for a copy.  Laron Z, Canlas BD, Crawford JD. The interaction of cortisone and vitamin D on bones of rachitic rats. AMA archives of pathology. 1958;65(4):403-406. – Please contact the medical library for a copy.  Laron Z, Chiarelli F, Morgese G. II diabete mellito di tipo uno in eta evolutiva. Cosmos. 1991;11:4-5. – Please contact the medical library for a copy.  Laron Z, Desai M, Silbergeld A. Girls with laron syndrome having positive growth hormone binding protein (GHBP) are less retarded in height than those lacking GHBP. Journal of Pediatric Endocrinology and Metabolism. 1997;10(3):305-307. – Please contact the medical library for a copy.  Laron Z, Dickerman Z, Arad J, Gurewitz R, Grunebaum M. Age at first conscious ejaculation. In: Pathophysiology at Puberty. ; 1980:117-121. – Please contact the medical library for a copy.  Laron Z, Dickerman Z, Kauli R. Treatment of premature and delayed puberty with LH- RH and its analogs. In: Seminars in Reproductive Endocrinology. ; 1987:421-429. – Please contact the medical library for a copy.  Laron Z, Dickerman Z, Ritterman I, Kaufman H. Follow-up of boys with unilateral compensatory testicular hypertrophy. Fertil Steril. 1980;33(3):297-301. – Please contact the medical library for a copy.  Laron Z, Dickerman Z, Ritterman I. Compensatory testicular hypertrophy in unilateral cryptorchidism. Cryptorchidism: diagnosis and treatment. 1979;6:137-147. – Please contact the medical library for a copy.  Laron Z, Dickerman Z, Zeev ZB, Prager-Lewin R, Comaru-Schally AM, Schally AV. Long-Term Effect of d-Trp6-Luteinizing Hormone-Releasing Hormone on Testicular Size and Luteinizing Hormone, Follicle-Stimulating Hormone, and Testosterone Levels in Hypothalamic Hypogonadotropic Males**Supported in part by the Harry C. Bernard Fund. Fertility and sterility. 1981;35(3):328-331. doi:10.1016/S0015- 0282(16)45381-1  Laron Z, Dickerman Z. Clomiphene in pubertal-adolescent gynecomastia. J Pediatr. 1978;92(1):169. doi:10.1016/S0022-3476(78)80119-X. – Please contact the medical library for a copy.  Laron Z, Dickerman Z. Usefulness of the LH-RH test in the choice of therapy in delayed puberty in boys. Recent Progress in Pediatric Endocrinology, Proc of the Serono Foundation Symposia, No 12. 1977:139-151. – Please contact the medical library for a copy.  Laron Z, Doron M, Amikam B. Plasma Growth Hormone in Men and Women over 70 Years of Age. In: Brunner D, Jokl E, eds. Physical Activity and Aging: With Special References to the Effect of Exercise and Training on the Natural History of Arteriosclerotic Heart Disease. Vol 4. Medicine and sport science. S. Karger AG; 1970:126-131. doi:10.1159/000387283. – Please contact the medical library for a copy.  Laron Z, Efros O. Prolactin serum levels in untreated and IGF-I treated patients with Laron syndrome are elevated and suppressed by IGF-I treatment (Abstract P76). Growth Horm IGF Res. 2010;20(1):S66.  Laron Z, Eliakim A. Basketball not only for the tall. Pediatric Endocrinology Reviews. 2006;3(3):232. – Please contact the medical library for a copy.  Laron Z, Fortunato J, Klein R. Serum alkaline phosphatase response to the administration of cortisone in rats. Endocrinology. 1957;61(5):483-487. – Please contact the medical library for a copy.  Laron Z, Frankel JJ, Amir S, et al. Long-term experience with a multidisciplinary, comprehensive ambulatory treatment scheme for diabetes mellitus in children. In: Psychological Aspects of Diabetes in Children and Adolescents. Pediatric & Adolescent Endocrinology Vol. 10. ; 1982:182-186. – Please contact the medical library for a copy.  Laron Z, Frenkel J, Deghenghi R, Anin S, Klinger B, Silbergeld A. Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clin Endocrinol (Oxf). 1995;43(5):631-635. doi:10.1111/j.1365-2265.1995.tb02929.x. – Please contact the medical library for a copy.  Laron Z, Frenkel J, Eshet R, Klinger B, Silbergeld A. Human growth hormone and insulin-like growth factor-I stimulating and growth promoting effects by long term intranasal administration of the hexapeptide - Hexarelin. (Abstract # P3-141). Proceedings 77th Annual Meeting of the Endocrine Society. 1995:504. – Please contact the medical library for a copy.  Laron Z, Frenkel J, Gil-Ad I, et al. Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clin Endocrinol (Oxf). 1994;41(4):539-541. doi:10.1111/j.1365-2265.1994.tb02589.x. – Please contact the medical library for a copy.  Laron Z, Frenkel J, Silbergeld A. 24. In: Growth Hormone Secretagogues in Clinical Practice. ; 1996:379-387. – Please contact the medical library for a copy.  Laron Z, Frenkel J, Silbergeld A. Biochemical and growth promoting effects of a growth hormone releasing peptide - Hexarelin (Hex) - in children. (Abstract #76). Horm Res. 1995;44(Suppl. 1):20. – Please contact the medical library for a copy.  Laron Z, Gaides M, Scheinowitz M, Wagner R, Ben-Dov I. Untreated patients with primary GH insensitivity (Laron syndrome) have reduced maximal aerobic capacity. (Abstract P1-123). Horm Res. 2000;53(Suppl. 2):37. – Please contact the medical library for a copy.  Laron Z, Galatzer A, Amir S, Gil R, Karp M, Mimouni M. A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care. 1979;2(4):342-348. doi:10.2337/diacare.2.4.342  Laron Z, Galatzer A, Fainmesser P, et al. Four years experience with the microcomputer system “Diacon” in the treatment and education of diabetes. Horm Metab Res Suppl. 1990;24:129-140. – Please contact the medical library for a copy.  Laron Z, Galatzer A, Kranzler JH, Rosenbloom AL. A comment on normal intelligence in growth hormone receptor deficiency [1] (multiple letters). Journal of Clinical Endocrinology and Metabolism. 1998;83(12):4528-4529.  Laron Z, Galatzer A. Effect of hGH on head circumference and IQ in isolated growth hormone deficiency. Early Hum Dev. 1981;5(2):211-214. doi:10.1016/0378- 3782(81)90054-2. – Please contact the medical library for a copy.  Laron Z, Gil-Ad I, Topper E, Kaufman H, Josefsberg Z. Low oral dose of clonidine: an effective screening test for growth hormone deficiency. Acta Paediatr Scand. 1982;71(5):847-848. doi:10.1111/j.1651-2227.1982.tb09532.x. – Please contact the medical library for a copy.  Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. Body adiposity is increasing progressively in both untreated and IGF-I treated patients with Laron syndrome (Abstract P2-571). Horm Res. 2005;64(1):167.  Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol (Oxf). 2006;65(1):114-117. doi:10.1111/j.1365-2265.2006.02558.x.  Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. Long-term IGF-I treatment of children with Laron syndrome increases adiposity. Growth Horm IGF Res. 2006;16(1):61-64. doi:10.1016/j.ghir.2005.12.001  Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaissman N. Body composition in adult patients with Laron syndrome. (Abstract #P3-100). 87th Annual Meeting of the Endocrine Society. 2005;Program an:567. – Please contact the medical library for a copy.  Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaissman N. Body composition of IGF-I treated girls with Laron syndrome. (Abstract #183). Pediatric Academic Societies 2005 Annual Meeting. 2005;57:1029. – Please contact the medical library for a copy.  Laron Z, Ginsberg S, Lilos P. Progressive and severe obesity and hypercholesterolemia from birth to adult age in patients with Laron syndrome (Primary GH insensitivity). (Abstract P1-349). Proceedings of the 86th Annual Meeting of The Endocrine Society. 2004:239. – Please contact the medical library for a copy.  Laron Z, Ginsberg S, Pariente C, Kanety H. Serum adiponectin levels are high in untreated and IGF-I treated patients with Laron syndrome (Abstract #PO3-418). Horm Res. 2007;68(Suppl. 1):128.  Laron Z, Ginsberg S, Pariente C, Kanety H. Serum adiponectin levels in patients with Laron syndrome are unexpectedly high (Abstract# P2-67). 89th Annual Meeting of The Endocrine. 2007. – Please contact the medical library for a copy.  Laron Z, Ginsberg S, Webb M. Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. Growth Horm IGF Res. 2008;18(5):434-438. doi:10.1016/j.ghir.2008.03.003  Laron Z, Gordon O. Geographic variation in the recurrence risk in close relatives of childhood onset IDDM patients. (Abstract #15). Diabetologia. 1994;37(Suppl. 1):A6. – Please contact the medical library for a copy.  Laron Z, Hochman IH, Keret R. The effect of methandrostenolone on pituitary growth hormone secretion in prepubertal children. Clin Endocrinol (Oxf). 1972;1(1):91-97. doi:10.1111/j.1365-2265.1972.tb00381.x. – Please contact the medical library for a copy.  Laron Z, Huerter P, Weber B. Standardization of Oral Glucose-Tolerance Tests. Acta Paediatrica Belgica. 1977;30(2):124-125. – Please contact the medical library for a copy.  Laron Z, Karp M, Dudek M, Kowadlo-Silbergeld A, Harel D. A contribution to the fat mobilizing activity of human growth hormone. Helvetica paediatrica acta. 1968;23(1):37-44. – Please contact the medical library for a copy.  Laron Z, Karp M, Fainmesser P, Assa S, Aurbach Y. Natural history of type I diabetes mellitus in childhood. Acta Paediatr Jpn. 1987;29(1):38-46. doi:10.1111/j.1442- 200x.1987.tb00007.x. – Please contact the medical library for a copy.  Laron Z, Karp M, Frankel JJ. A Study of the Rehabilitation of Juvenile and Adolescent Diabetics in the Central Region of Israel. Kupat Holim Press; 1972:1-202, (Appendix 1 pg. 1-88). – Please contact the medical library for a copy.  Laron Z, Karp M, Golomb A, KOWADLOS.A, Dudek M, Harel D. Lipolytic Effect of Epinephrine and Growth Hormone in Obesity - in Vivo and in Vitro Studies. Acta Paediatrica Scandinavica. 1968;57(1):82–.– Please contact the medical library for a copy.  Laron Z, Karp M, Kauli R, PERTZELA.A. Insulin, Growth and Growth-Hormone. Israel Journal of Medical Sciences. 1972;8(3):440-452. – Please contact the medical library for a copy.  Laron Z, Karp M. 44. Diabetes Mellitus in Children and Adolescents In: Bertrand J 1925-, Rappaport R (Raphaël), Sizonenko PC, eds. Pediatric Endocrinology : Physiology, Pathophysiology and Clinical Aspects. 2nd ed. Baltimore : Williams & Wilkins, c1993.; 1993:597-617. – Please contact the medical library for a copy.  Laron Z, Karp M. Carbohydrate metabolism in the syndrome of familial dwarfism and high plasma immunoreactive growth hormone (Laron type dwarfism). In: Secondary Diabetes: The Spectrum of the Diabetic Syndrome. ; 1980:363-371. – Please contact the medical library for a copy.  Laron Z, Karp M. Evaluation of morning and noon blood sugar concentrations, 24 hour urine sugar excretion und daily urine examination as indices of diabetic control. In: Medical Aspects of Balance of Diabetes in Juveniles. Basel München Paris London New York Sydney: S. Karger; 1977:29-35. – Please contact the medical library for a copy.  Laron Z, Kauli R, Bisker O. Long-term hGH treatment of children with congenital isolated GH deficiency augments subcutaneous fat tissue (Abstract P2-d3-776). Horm Res Paediatr. 2010;74(3):231-232. – Please contact the medical library for a copy.  Laron Z, Kauli R. Experience with cyproterone acetate in the treatment of precocious puberty. J Pediatr Endocrinol Metab. 2000;13 Suppl 1:805-810. doi:10.1515/jpem.2000.13.s1.805. – Please contact the medical library for a copy.  Laron Z, Kaushanski A, Josefsberg Z. Penile size and growth in children and adolescents with isolated gonadotrophin defiency (IGnD). Clin Endocrinol (Oxf). 1977;6(4):265-270. doi:10.1111/j.1365-2265.1977.tb02010.x. – Please contact the medical library for a copy.  Laron Z, Kelijman M, Pertzelan A, Keret R, Shoffner JM, Parks JS. Human growth hormone gene deletion without antibody formation or growth arrest during treatment--a new disease entity? Isr J Med Sci. 1985;21(12):999-1006. – Please contact the medical library for a copy.  Laron Z, Keret R, Bauman B, et al. Differential diagnosis between hypothalamic and pituitary hGH deficiency with the aid of synthetic GH-RH 1-44. Clin Endocrinol (Oxf). 1984;21(1):9-12. doi:10.1111/j.1365-2265.1984.tb00130.x. – Please contact the medical library for a copy.  Laron Z, Kisselgof O, Steinberg DM, Toren Y, Feinberg M, Scheinowitz M. IGF-I replacement therapy in children with congenital IGF-I deficiency restore heart dimension and function in children with Laron syndrome. (Abstract #A7). Israel Heart Association Annual Meeting. 2007:Abstract #A7. – Please contact the medical library for a copy.  Laron Z, Klinger B, Anin S, Pertzelan A, Lilos P. Growth during and 2 years after stopping GH treatment in prepubertal children with idiopathic short stature. J Pediatr Endocrinol Metab. 1997;10(2):191-196. doi:10.1515/jpem.1997.10.2.191. – Please contact the medical library for a copy.  Laron Z, Klinger B, Blieden L, Wang XL. Role of Growth Hormone (GH) and IGF-I in Cardiovascular Pathology. Isr J Med Sci. 1996;32:1002. – Please contact the medical library for a copy.  Laron Z, Klinger B, Blum WF, Silbergeld A, Ranke MB. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I. Clin Endocrinol (Oxf). 1992;36(3):301-304. doi:10.1111/j.1365-2265.1992.tb01449.x. – Please contact the medical library for a copy.  Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci. 1993;29(12):757- 763. – Please contact the medical library for a copy.  Laron Z, Klinger B, Grunebaum M, Feingold M, Tunnessen WW. Picture of the month. Laron-type dwarfism. Am J Dis Child. 1991;145(4):473-474. doi:10.1001/archpedi.1991.02160040135023. – Please contact the medical library for a copy.  Laron Z, Klinger B, Jensen LT, Erster B. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism. Clin Endocrinol (Oxf). 1991;35(2):145-150. doi:10.1111/j.1365-2265.1991.tb03513.x. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A, Deghenghi R. Long-term intranasal (i.n.) treatment of children with Hexarelin induces partial and reversible desensitization. (Abstract #OR46-4). Proceedings 10th International Congress of Endocrinology. 1996:709. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A, Lewin R, Erster B, Gil-Ad I. Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinol. 1990;123(3):378-382. doi:10.1530/acta.0.1230378. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A, Wang XL. Opposing effects of growth hormone and insulin-like growth factor I on serum lipoprotein(a). Journal of Pediatric Endocrinology and Metabolism. 1997;10(SUPPL. 1):143-149. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A, Wang XL. P-013. Growth hormone (GH) treatment increases and IGF-I treatment decreases serum lipoprotein-a [Lp(a)] levels. Endocrinology and Metabolism, Supplement. 1997;4(A):40-41. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A, Wilcken D, Wang XL. 1148. J Pediat Endocrinol Metab. 1996;9(Suppl. 2):218. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A, Wilcken D, Xl W. IGF-I and hGH have opposing effects on serum lipoprotein-(a) [Lp (a)] (Abstract). Progress on Childhood Diabetes Including Recent Progress on Growth Hormone - Editoriale Bios. 1997;(6th International ISPAD Course):163. – Please contact the medical library for a copy.  Laron Z, Klinger B, Silbergeld A. Patients with Laron Syndrome Have Osteopenia/Osteoporosis. J Bone Miner Res. 1999;14(1):156-156. doi:10.1359/jbmr.1999.14.1.156  Laron Z, Klinger B, Silbergeld A. Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF- I treatment of children and adults with primary GH resistance (Laron syndrome). Journal of Pediatric Endocrinology and Metabolism. 1999;12(2):145-152. – Please contact the medical library for a copy.  Laron Z, Klinger B. Are patients with Laron syndrome candidates for limb lengthening? In: Limb Lengthening: For Whom, When and How?. ; 1995:79-91. – Please contact the medical library for a copy.  Laron Z, Klinger B. Body fat in Laron syndrome patients: Effect of insulin-like growth factor I treatment. Hormone Research. 1993;40(1-3):16-22. – Please contact the medical library for a copy.  Laron Z, Klinger B. Comparison of the growth-promoting effects of insulin-like growth factor I and growth hormone in the early years of life. Acta Paediatrica, International Journal of Paediatrics. 2000;89(1):38-41. – Please contact the medical library for a copy.  Laron Z, Klinger B. Does intensive sport endanger normal growth and development? In: Hormones and Sport. ; 1989:1-9. – Please contact the medical library for a copy.  Laron Z, Klinger B. Effect of IGI-I treatment on obesity in laron type dwarfism. Diabetes in the Young. 1992;34:P40. – Please contact the medical library for a copy.  Laron Z, Klinger B. Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol. 1998;138(2):176-180. doi:10.1530/eje.0.1380176  Laron Z, Klinger B. IGF-I increases androgens in Laron Syndrome. Horm Res. 1997;48(S2):44. – Please contact the medical library for a copy.  Laron Z, Klinger B. IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin Endocrinol (Oxf). 1994;41(5):631-638. doi:10.1111/j.1365- 2265.1994.tb01829.x. – Please contact the medical library for a copy.  Laron Z, Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Horm Res. 1994;42(4-5):198-202. doi:10.1159/000184193. – Please contact the medical library for a copy.  Laron Z, Klinger B. Laron Syndrome: Molecular and Clinical Aspects. Pediat Adolesc Endocrinol. 1993;24:367. – Please contact the medical library for a copy.  Laron Z, Klinger B. One year treatment with igf-1 of children with laron syndrome (ls). Pediatr Res. 1993;33:S5-S5. doi:10.1203/00006450-199305001-00019  Laron Z, Kordonouri O, Shuga N, Lewy H, Ashkenazi I. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in Berlin differs from the general population. Eur J Pediatr. 2002;161(5):291-292. doi:10.1007/s00431-002- 0941-9  Laron Z, Kornreich L, Hershkovitz I. Did the small-bodied hominis from Flores (Indonesia) suffer from a molecular defect in the growth hormone receptor gene (Laron syndrome)? Pediatric Endocrinology Reviews. 2006;3(4):345-346. – Please contact the medical library for a copy.  Laron Z, Kornreich L. Patients with primary GH insensitivity (Laron syndrome) have a narrow cervical spinal canal and oropharynx. (Abstract P1-124). Horm Res. 2000;53(Suppl. 2):38. – Please contact the medical library for a copy.  Laron Z, Kornreich L. Pituitary size in primary growth hormone (GH) resistance (Laron syndrome). (Abstract #107). GH & IGF Res. 2002;12:260. – Please contact the medical library for a copy.  Laron Z, Kornreich L. Untreated Laron Syndrome Patients Have Diffused Brain Parenchymal Loss. Pediatr Res. 2001;49(76A):P1-448. – Please contact the medical library for a copy.  Laron Z, KOWADLOS.A. Effect of Testosterone and Methandrostenolone (Dianabol) on Plasma Free Fatty Acids in Intact Female and Castrated Male Rats. Israel Journal of Medical Sciences. 1965;1(1):91-92. – Please contact the medical library for a copy.  Laron Z, Kowadlo-sibergeld A. FAT MOBILISING EFFECT OF OESTROGENS. Acta Endocrinologica. 1965;48:125-131. – Please contact the medical library for a copy.  Laron Z, Kowadlo-Silbergeld A, Eshet R, Pertzelan A. Growth hormone resistance. Ann Clin Res. 1980;12(5):269-277. – Please contact the medical library for a copy.  Laron Z. Resistance to growth hormone. Journal of Endocrinology. 1991; 129: (Abst. 7) – Please contact the medical library for a copy.  Laron Z, Lazar L, Galatzer A, Pertzelan A. {Growth hormone treatment accelerates head circumference growth in isolated GH deficiency}.‏ In: Essays on Auxology. Castlemead, 1995489-495:‏;‏..‏ – Please contact the medical library for a copy.  Laron Z, Lewy H, Ashkenazi I, Hummel M, Ziegler AG. IAA/GAD positive offspring of diabetic parents have a different seasonality in month of birth than antibody- negative offspring. J Pediatr Endocrinol Metab. 2001;14(Suppl. 3):1029. – Please contact the medical library for a copy.  Laron Z, Lewy H. Worldwide epidemiological surveys of month of birth support the viral etiology of childhood onset Type 1 diabetes. (Abstract # P65). Annual Meeting of the Israel Endocrine Society. 2003:Abstract #P65. – Please contact the medical library for a copy.  Laron Z, Lewy H. Worldwide epidemiological surveys of month of birth support the viral etiology of childhood onset Type 1 diabetes. (Abstract # P-7). J Pediatr Endocrinol Metab. 2003;16(Suppl. 1):928. – Please contact the medical library for a copy.  Laron Z, Lewy H. Worldwide epidemiological surveys of month of birth support the viral etiology of childhood onset Type 1 diabetes Abstract P-7. journal of pediatric endocrinology & Metabolism. 2003;16(Suppl. 4):928. – Please contact the medical library for a copy.  Laron Z, Lilos P, Klinger B. Growth curves for Laron syndrome. Arch Dis Child. 1993;68(6):768-770. doi:10.1136/adc.68.6.768  Laron Z, Lilos P, Pertzelan A, S A, Klinger B. Long term treatment of short prepubertal children improves their height. Pediatric Research. 1993;33(Suppl. 56):Abstract 315.  Laron Z, Lilos P, Sivan B. The effect of IGF-I deficiency and replacement therapy on the hematopoietic system in patients with primary GH insensitivity (Laron syndrome). (Abstract #OR1-26). Horm Res. 2002;58(Suppl. 2):9. – Please contact the medical library for a copy.  Laron Z, Mansour T, Gordon O, Karp M, Shohat T. Ethnic differences in the incidence of childhood diabetes in Israel. Diabetes Res Clin. 1991;14(Suppl. 1):S76. – Please contact the medical library for a copy.  Laron Z, Mansour T, Slepon R, Karp M, Shohat T. Incidence of diabetes mellitus in various population groups in Israel (1989 and 1990). Isr J Med Sci. 1994;30(10):770- 774. – Please contact the medical library for a copy.  Laron Z, Meyerovitch, Silbergeld A, Wasserman M. Treatment of adults with growth hormone deficiency. Annual Meeting of the Israel Endocrine Society. 1993:Abstracts S3. – Please contact the medical library for a copy.

 Laron Z, Mimouni F, Pertzelan A. Effect of human growth hormone therapy on penile and testicular size in boys with isolated growth hormone deficiency: first year of treatment. Isr J Med Sci. 1983;19(4):338-344. – Please contact the medical library for a copy.  Laron Z, Mimouni F. Confusion around the definition of small for gestational age (SGA). Pediatr Endocrinol Rev. 2005;2(3):364-365. – Please contact the medical library for a copy.  Laron Z, Mimouni M. Diabete sucre. In: Endocrinologie Pediatrique. ; 1982:607-632. – Please contact the medical library for a copy.  Laron Z, Muhlethaler JP, Klein R. The interrelationship between cortisone and parathyroid extract in rats. AMA archives of pathology. 1958;65(2):125-130. – Please contact the medical library for a copy.  Laron Z, Özön A, Neyzi O. Interactions between the thyroid hormones and the hormones of the growth hormone axis. Pediatric Endocrinology Reviews. 2003;1(SUPLL. 2):244-250. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Doron M, Assa S, Keret R. The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. Horm Metab Res. 1977;9(4):338-339. doi:10.1055/s-0028-1095565. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Frankel J. Growth and development in the syndromes of familial isolated absence of HGH or pituitary dwarfism with high serum concentration of an immunoreactive. Hormones in Development. 1971:573-585. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Karp M, Keret R. {Laron Syndrome-a unique model of IGF-1 deficiency}.‏ In: Lessons from Laron Syndrome (LS), 1966-1992. Vol 24. ; 1993:3-23. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, Daughaday WH. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab. 1971;33(2):332-342. doi:10.1210/jcem-33-2-332. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Karp M. Glucose Intolerance in Children and Young Adults with Dwarfism due to HGH Deficiency and with the Syndrome of Dwarfism and High Plasma IR-HGH. In: Laron Z, ed. Diabetes in Juveniles: 2nd International Beilinson Symposium, Jerusalem 1972 1st Edition Has Been Published as: Modern Problems in Paediatrics, Vol. 12. S. Karger AG; 1977:109-117. doi:10.1159/000400779. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci. 1968;4(4):883-894. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Kauli R. Growth and developmental follow-up forms. J Pediatr Endocrinol Metab. 1998;11(2):283-284. doi:10.1515/jpem.1998.11.2.285. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Kiwity S, Livneh-zirinisky M, Keret R. Growth without growth hormone: Myth or fact? In: Convegno Internazionale Di Endocrinologia Pediatrica. ; 1975:131-152. – Please contact the medical library for a copy.  Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism? Isr J Med Sci. 1966;2(2):152-155. – Please contact the medical library for a copy.  Laron Z, Pertzelan A. Growth hormone treatment (Editorial). Harefuah. 1981;100(4):191-192. – Please contact the medical library for a copy.  Laron Z, Pertzelan A. Puberty in Laron-type dwarfism - a model for untreated congenital isolated growth hormone deficiency. In: Induction of Puberty in Hypopituitarism. ; 1988:39-47. – Please contact the medical library for a copy.  Laron Z, Pertzelan A. Somatotrophin in antenatal and perinatal growth and development. Lancet (London, England). 1969;1(7596):680-681. – Please contact the medical library for a copy.  Laron Z, Phillip M, Kalter-Leibovici O. 50. In: Argente J, ed. Tratado de Endocrinología Pediátrica y de La Adolescencia. 2a ed. Barcelona: Barcelona : Doyma, 2000.; 2000:1267-1288. – Please contact the medical library for a copy.  Laron Z, Pollack MS, Zamir R, et al. Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: A new Allele at the 21-hydroxylase locus. Hum Immunol. 1980;1(1):55-66. doi:10.1016/0198-8859(80)90009-9. – Please contact the medical library for a copy.  Laron Z, Prager‐Lewin R, Dickerman Z. 28. Diagnostic uses of LFI-RH. In: LH-RFI and Its Analogs — Contraceptive and Therapeutic Applications. Lacanster, England; 1984:367-374. – Please contact the medical library for a copy.  Laron Z, Roitman A, Kauli R, Zachmann M, Sorgo W. Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone. Eur J Pediatr. 1980;135(2):221-221. doi:10.1007/BF00441646. – Please contact the medical library for a copy.  Laron Z, Roitman A, Pollack MS, Dupont B. To the Editor. Fertility and sterility. 1980;34(1):76. doi:10.1016/S0015-0282(16)44851-X. – Please contact the medical library for a copy.  Laron Z, Rotstein A, Kahana E, et al. Multiple sclerosis and celiac disease patients similar to childhood type 1 diabetes have an abnormal seasonality of birth (Abstract O-8). Pediatric Diabetes. 2005;6(3):12.  Laron Z, Sarel R, Hochberg Z, Pertzelan A. Puberty in Laron-type dwarfism. In: Pathophysiology at Puberty. ; 1980:197-206. – Please contact the medical library for a copy.  Laron Z, Sarel R. Penis and testicular size in patients with growth hormone insufficency. Acta endocrinologica. 1970;63(4):625-633. – Please contact the medical library for a copy.  Laron Z, Scheinowitz M, Kisselgof O, Toren Y, Steinberg DM, Feinberg MS. Heart dimensions and functions are dependent upon IGF-I availability (Abstract # PO3- 565). Horm Res. 2007;68(Suppl. 1):175.  Laron Z, Shamis I, Ashkenazi I. Inverse Relationship between Month of Birth and Month of Onset of IDDM in Jewish Children in Israel. Diabetes. 1998;47(1S):149A. – Please contact the medical library for a copy.  Laron Z, Shamis I, Gordon O, Albag Y. Increased incidence of childhood IDDM (0-17 yr) in Israel since 1985. (Abstract #38). J Pediat Endocrinol Metab. 1995;8(Suppl):224. – Please contact the medical library for a copy.  Laron Z, Shamis I, Nitzan-Kaluski D, Ashkenazi I. Month of birth and subsequent development of type I diabetes (IDDM). Journal of Pediatric Endocrinology and Metabolism. 1999;12(3):397-402. – Please contact the medical library for a copy.  Laron Z, Shevah O, Borrelli P, Rubinstein M. Two novel mutations in the GH receptor gene. (Abstract #P1-164). Horm Res. 2002;58(Suppl. 2):49. – Please contact the medical library for a copy.  Laron Z, Shevah O, Rubinstein M. Similarity of GH-R gene mutations in Laron syndrome from different ethnic groups. (Abstract #217). GH & IGF Res. 2002;12:297. – Please contact the medical library for a copy.  Laron Z, Shevah O, Rubinstein M. Variability in the Molecular Defects of the GH-R Gene in the Israeli Cohort of Patients with Laron Syndrome (GH Insensitivity). Endocrine Society 8th Annual Meeting. 2002;(P3-532):616. – Please contact the medical library for a copy.  Laron Z, Shevah O. Congenital IGF-I deficient patients are protected from cancer, no so their 1st and 2nd degree relatives (Abstract #OR02-2). Growth Horm & IGF-I Res. 2006;16(Suppl. B):S3-S4. – Please contact the medical library for a copy.  Laron Z, Silber A, Pertzelan A. Growth Hormone Resistant Syndromes. In: Human Growth Hormone. Vol 3. ; 1986:163-178. – Please contact the medical library for a copy.  Laron Z, Silbergeld A, Blum FWF. Serum Leptin Levels in Patients With Laron Syndrome Before and During IGF-I Treatment. Horm Res. 1997;48(S2):44. – Please contact the medical library for a copy.  Laron Z, Silbergeld A, Blum FWF. Serum Leptin Levels In Untreated and IGF-I Treated Patients with Laron Syndrome (LS). In: The Endocrine Society 79th Annual Meeting. Minneapolis, Minnesota; 1997:P3-138. – Please contact the medical library for a copy.  Laron Z, Silbergeld A, Klinger B. Hyperandrogenism induced by insulin-like growth factor-I (IGF-I) treatment of two girls with Laron syndrome. Children’s Hospital Quarterly. 1998;10(2):75-79. – Please contact the medical library for a copy.  Laron Z, Silbergeld A, Lilos P, Blum FWF. Serum leptin in obese patients with Laron syndrome before and during IGF-I treatment. Journal of Pediatric Endocrinology and Metabolism. 1998;11(5):653-656. – Please contact the medical library for a copy.  Laron Z, Silbergeld A, Lilos P. Foot size in untreated adult patients with Laron syndrome (LS) and foot growth in children with LS during IGF-I therapy (Abstract #P- 35). Growth Horm & IGF-I Res. 2006;16(Suppl. B):S32. – Please contact the medical library for a copy.  Laron Z, Silbergeld A. A simple diagnostic screening test for children with short stature - With emphasis on genetic defects along the GH axis. Pediatric Endocrinology Reviews. 2006;4(2):96-98. – Please contact the medical library for a copy.  Laron Z, Suikkari AM, Klinger B, et al. Growth-Hormone and Insulin-Like Growth- Factor Regulate Insulin-Like Growth Factor-Binding Protein-1 in Laron Type Dwarfism, Growth-Hormone Deficiency and Constitutional Short Stature. Acta Endocrinologica. 1992;127(4):351-358. – Please contact the medical library for a copy.  Laron Z, Taube E, Kaplan I. Pituitary growth hormone insufficiency associated with cleft lip and palate. An embryonal developmental defect. Helvetica paediatrica acta. 1969;24(6):576-581. – Please contact the medical library for a copy.  Laron Z, Topper E, Gil-Ad I. {Oral clonidine — a simple, safe and effective test for growth hormone secretion.}. Evaluation of Growth Hormone Secretion Pediatric & Adolescent Endocrinology. 1983;12:103-115. – Please contact the medical library for a copy.  Laron Z, Topper E, Karp M, et al. Relationship between newborn size and development and therapeutic regime of insulin dependent diabetic mothers. In: Carbohydrate Metabolism in Pregnancy and the Newborn. ; 1984:152-160. – Please contact the medical library for a copy.  Laron Z, Topper E. Testicular Volumes of Adolecents (Letter). Journal of Pediatrics. 1983;103:503-504. – Please contact the medical library for a copy.  Laron Z, Wang X, Klinger B, Silbergeld A, Wilcken D. IGF-I lowers and hGH raises serum lipoprotein-(a). (Abstract #1182). Diabetes. 1996;45(Suppl. 2):317A. – Please contact the medical library for a copy.  Laron Z, Wang XL, Klinger B, et al. Growth hormone treatment increases circulating lipoprotein(a) in children with chronic renal failure. Journal of Pediatric Endocrinology and Metabolism. 1996;9(5):533-537. – Please contact the medical library for a copy.  Laron Z, Wang XL, Klinger B, Silbergeld A, Wilcken DE. Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a). Eur J Endocrinol. 1997;136(4):377-381. doi:10.1530/eje.0.1360377. – Please contact the medical library for a copy.  Laron Z, Wang XL, Klinger B, Silbergeld A, Wilcken DE. Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndrome. Metab Clin Exp. 1996;45(10):1263-1266. doi:10.1016/s0026- 0495(96)90245-0  Laron Z, Wang Y. Is obesity associated with early sexual maturation? Pediatrics. 2004;113(1):171-172. doi:10.1542/peds.113.1.171  Laron Z, Wasserman M, Neuhaus H, Y.Meyerovitch, Silbergeld A. Retreatment of young adult growth hormone deficient patients. In: Growth Hormone Replacement Therapy in Adults : Pros and Cons. ; 1993:99-114. – Please contact the medical library for a copy.  Laron Z, Wasserman M. Should Growth Hormone Administration to GH Deficient Adolescents be Continued After Reaching Final Height? In: Pombo M (Manuel), Rosenfeld RG, eds. Two Decades of Experience in Growth : International Symposium : Papers. Proceeding. ; 1993. – Please contact the medical library for a copy.  Laron Z, Weinberger D, Hellstrom A. Reduced retinal vascularization and branching in patients with Laron syndrome (primary IGF-I deficiency). Annual Meeting of the Israel Endocrine Society. 2001;Abstract B:P51. – Please contact the medical library for a copy.  Laron Z, Weinberger D. Diabetes and its vascular complications in congenital IGF-I deficiency (Laron syndrome - growth hormone insensitivity). (Abstract. #P1-149). Hormone Research in Paediatrics. 2003;60(Suppl. 2):43. – Please contact the medical library for a copy.  Laron Z, Weinberger D. Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome). Eur J Endocrinol. 2004;151(1):103-106. doi:10.1530/eje.0.1510103  Laron Z, Weinberger D. Diabetic retinopathy, nephropathy and cardiovascular disease in a patient with GH gene deletion. Clin Endocrinol (Oxf). 2005;63(6):699- 700. doi:10.1111/j.1365-2265.2005.02402.x  Laron Z, Weinberger D. Diabetic retinopathy, nephropathy and cardiovascular disease in a patient with GH-N gene deletion (Abstract P-74). Pediatric Diabetes6. 2005;6(3):53-54. – Please contact the medical library for a copy.  Laron Z, Weinberger D. Diabetic retinopathy, nephropathy and cardiovascular disease in growth hormone (GH) gene deletion. (Abstract #2315-PO). 65th Annual Meeting of the American Diabetes Association (ADA). 2005;Abstract B:A558. – Please contact the medical library for a copy.  Laron Z, Werne H. Est-ce-que les nouveaux analogues d’insuline à action longue ont une action mitogenique ? 2010:1-3. http://www.sfedp.org/jep/2010/02/26/est-ce- que-les-nouveaux-analogues-d-insuline-a-action-longue-ont-une-action- mitogenique/. Accessed April 4, 2017. – Please contact the medical library for a copy.  Laron Z, Yed-Lekach A, Assa S, Kowadlo-Silbergeld A. Effect of heat on the immunological properties of human, bovine and ovine growth hormone. Acta Endocrinol. 1964;46:465-472. doi:10.1530/acta.0.0460465. – Please contact the medical library for a copy.  Laron Z, Yed-Lekach A, Assa S, Kowadlo-Silbergeld A. Immunochemical properties of bovine and human pituitary growth hormone after pepsin digestion. Endocrinology. 1964;74:532-537. doi:10.1210/endo-74-4-532. – Please contact the medical library for a copy.  Laron Z, Yed-Lekach A, Assa S, Kowadlo-Silbergeld A. Influence of heat and pepsin digestion on the immunochemical properties of sheep prolactin. J Endocrinol. 1965;32:267-268. doi:10.1677/joe.0.0320267. – Please contact the medical library for a copy.  Laron Z, Z. L, Laron Z. Psycho-social problems of diabetic children and adolescents. Acta Diabetologica Latina. 1984;21(1):35-46. – Please contact the medical library for a copy.  Laron Z, Zadik Z, Pertzelan A, Roitman A. Growth disturbances in hypothalamic pituitary diseases. In: Auxology: Human Growth in Health and Disorder. Proc. Serono Symp., Vol. 13,. ; 1978:239-252. – Please contact the medical library for a copy.  Laron Z. [The development of international pediatric diabetes organizations]. Rev Med Brux. 2010;31(2 Suppl):S25-8.  Laron Z. {Diabetes — a challenge to the insurance companies. (Hebrew).}. Insurance in Israel. 1984;111:7-8. – Please contact the medical library for a copy.  Laron Z. {Endocrine aspects of fetal growth — including the perinatal period.}. In: The Endocrine Physiology of Pregnancy and the Periportal Period. ; 1985:195-203. – Please contact the medical library for a copy.  Laron Z. {SYNDROME OF FAMILIAL DWARFISM AND HIGH PLASMA IMMUNOREACTIVE GROWTH-HORMONE (IR-HGH)-LARON-TYPE DWARFISM}.‏ Paediatrician,. 1977;6:106-117. – Please contact the medical library for a copy.  Laron Z. 14. In: Argente J, ed. Tratado de Endocrinología Pediátrica y de La Adolescencia. 2nd ed. Barcelona; 2000:339-355. – Please contact the medical library for a copy.  Laron Z. 17. In: George P. Chrousos JMO Ellis Samols, ed. Hormone Resistance and Hypersensitivity States. ; 2002:251-268. – Please contact the medical library for a copy.  Laron Z. 20. In: Ghigo E, Boghen M, Casanueva F f., Dieguez C, eds. Growth Hormone Secretagogues in Clinical Practice. ; 1999:247-261. – Please contact the medical library for a copy.  Laron Z. 23. In: Benso L, Gilli G (Giulio), Schell LM, International Association for Human Auxology, eds. Human Growth from Conception to Maturity. London: Smith- Gordon; 2002:215-225. – Please contact the medical library for a copy.  Laron Z. 32. In: Insulin-like Growth Factors. Georgetown, TX, USA: Landes Bioscience/Eureka.com; 2003:467-492. – Please contact the medical library for a copy.  Laron Z. Abnormal puberty. (HEBREW). Israel Growth and Development Association (IGA) Bulletin. 1995;15:6-7. – Please contact the medical library for a copy.  Laron Z. Age at first ejaculation (spermarche) - The overlooked milestone in male development. Pediatric Endocrinology Reviews. 2010;7(3):256-257. – Please contact the medical library for a copy.  Laron Z. Ambulatory multidisciplinary treatment of children with diabetes. Arch Dis Child. 2005;20:342-345. – Please contact the medical library for a copy.  Laron Z. An update on Laron syndrome. Arch Dis Child. 1993;68(3):345-346. doi:10.1136/adc.68.3.345  Laron Z. Atherosclerosis starts in childhood--fact, myth or insinuation? Z Gerontol. 1991;24(2):70-72. – Please contact the medical library for a copy.  Laron Z. Biologic and clinical aspects of molecular defects along the growth hormone- insulin-like growth factor I axis. In: Pediatric Endocrinology: Mechanisms, Manifestations, and Management. Chap. 9. ; 2004:123-150. – Please contact the medical library for a copy.  Laron Z. Can administration of growth hormone or IGF-I improve limb lengthening? In: Limb Lengthening: For Whom, When and How?. ; 1995:231-237. – Please contact the medical library for a copy.  Laron Z. Can one organize a multidisciplanary team to treat IDDM. In: Progress on Childhood Diabetes Including Recent Progress on Growth Hormone - Editoriale Bios. ; 1997:63-64. – Please contact the medical library for a copy.  Laron Z. Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults. Growth Horm IGF Res. 2000;10(4):230-231. doi:10.1054/ghir.2000.0161. – Please contact the medical library for a copy.  Laron Z. Childhood diabetes mellitus with emphasis on perinatal factors. Nestle Nutr Workshop Ser Pediatr Program. 2006;57:67-77; discussion 77. doi:10.1159/000091051. – Please contact the medical library for a copy.  Laron Z. Childhood diabetes towards the 21st century. Journal of Pediatric Endocrinology and Metabolism. 1998;11(3):387-402. – Please contact the medical library for a copy.  Laron Z. Childhood-onset growth harmone deficiency, cognitive function and brain N-acetylaspartate. Psychoneuroendocrinology. 2006;31(5):680-680. doi:10.1016/j.psyneuen.2005.12.004  Laron Z. Children diabetes and the 21st century (abstract). In: IDF Congress Daily News July 1997. – Please contact the medical library for a copy.  Laron Z. Clinical aspects of pituitary dwarfism and related conditions. In: Daughaday WH (Ed. ). (1981). E control of growth, ed. Endocrine Control of Growth Vol. 1. North-Holland.; 1981:175-205. – Please contact the medical library for a copy.  Laron Z. Clinical trials with IGF-I. In: Human Growth: Basic and Clinical Aspects. ; 1992:19-24. – Please contact the medical library for a copy.  Laron Z. Clinical use of somatomedin-1 yes or no? Paediatric Drugs. 1999;1(3):155- 159.  Laron Z. Comparison between hGH and IGF-1. PEDIATRIC AND ADOLESCENT ENDOCRINOLOGY. 1993;24:319-321. – Please contact the medical library for a copy.  Laron Z. Comparison between hGH and IGF-I. Theoretical and practical aspects of the treatment of diabetic children. 1993:73-75. – Please contact the medical library for a copy.  Laron Z. Congenital hypoparathyroidism. Isr J Med Sci. 1995;31(5):326-327. – Please contact the medical library for a copy.  Laron Z. Congenital IGF-I deficiency causes dwarfism, obesity, insulin resistance and predisposes for diabetes and vascular complications. (Abstract.# P.307). Pediat Res. 2003;53(Suppl.):26A. – Please contact the medical library for a copy.  Laron Z. Consequences of not treating children with Laron syndrome (primary growth hormone insensitivity). Journal of Pediatric Endocrinology and Metabolism. 2001;14(SUPPL. 5):1243-1248. – Please contact the medical library for a copy.  Laron Z. Deficiencies of growth hormone and somatomedins in man. Special topics in endocrinology and metabolism. 1983;5:149-199. – Please contact the medical library for a copy.  Laron Z. Definition and classification of short stature. In: Laron Z, Mastragostino S, Romano C, eds. Limb Lengthening for Whom, When & How?. London: Freund; 1995:3-8. – Please contact the medical library for a copy.  Laron Z. Development and biological function of the female gonads and genitalia in IGF-I deficiency - Laron syndrome as a model. Pediatric Endocrinology Reviews. 2006;3(SUPPL. 1):188-191. – Please contact the medical library for a copy.  Laron Z. Développement psychosocial et intellectuel au cours d’un traitement par hormone de croissance au long cours chez les enfants nés avec un retard de croissance intra-utérin (RCIU). J d’Endocrinol Pediatr. 2005:1-2. – Please contact the medical library for a copy.  Laron Z. Diabetes in childhood and adolescence: The role of nutrition. In: Clinical Nutrition of the Young Child : Volume 2. ; 1995:603-619. – Please contact the medical library for a copy.  Laron Z. Diabetes Mellitus in childhood - Definition and classification. Theoretical and practical aspects of the treatment of diabetic children. 1993:9-11. – Please contact the medical library for a copy.  Laron Z. Diabetes Mellitus in childhood - Definition and classification. In: 3rd International ISGD Course on Update on Diabetes in Childhood. ; 1991:9-11. – Please contact the medical library for a copy.  Laron Z. Diabetes mellitus in childhood. Definition and classification. In: Theoretical and Practical Aspects of the Treatment of Diabetic Children : 5th International ISPAD Course; Sesto Alta Val Pusteria (BZ), Dolomiti (Italy), March 11-18, 1995. ; 1995:9-11. – Please contact the medical library for a copy.  Laron Z. Diabetes Promotion - the Team-Approach. In: Rifkin H, Colwell JA, Taylor SI (eds.) Diabetes. 1991;908-911. – Please contact the medical library for a copy.  Laron Z. Diabetes mellitus - sozial-psychologische Aspekte der optimalen Einstellung. In: Abteilung MAGW, ed. Wissenschaftliche Information. Padiatrische Spezialambulanzen Technik Der Langzeittuberwachung — Symposium in Wetzlar. Milupa AG, Wissenschaftliche Abteilung; 1980:43-54. – Please contact the medical library for a copy.  Laron Z. Diagnosis and treatment of Laron syndrome (primary IGF-I deficiency). (in Spanish). Endocrinologia. 1998:53-58. – Please contact the medical library for a copy.  Laron Z. Disorders of growth hormone resistance in childhood. Curr Opin Pediatr. 1993;5(4):474-480. doi:10.1097/00008480-199308000-00018. – Please contact the medical library for a copy.  Laron Z. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev. 2005;126(2):305-307. doi:10.1016/j.mad.2004.08.022. – Please contact the medical library for a copy.  Laron Z. Does childhood diabetes start in utero? Rivista Italiana di Pediatria. 2001;27(4):397. – Please contact the medical library for a copy.  Laron Z. Effect of corticosteroid and combined corticosteroid-anabolic therapy on body height. In: Somatic Growth of the Child. ; 1966:329-334. – Please contact the medical library for a copy.  Laron Z. Effect of insulin-like growth factor I on IGF binding proteins. J Pediatr. 1993;123(1):169-170. doi:10.1016/S0022-3476(05)81573-2. – Please contact the medical library for a copy.  Laron Z. Effects of growth hormone and IGF-I deficiency on life span. Signal Transduction in Health and Disease (STADY). 2002:52. – Please contact the medical library for a copy.  Laron Z. Effects of Growth Hormone and Insulin-Like Growth Factor 1 Deficiency on Ageing and Longevity. In: Chadwick DJ, Goode JA, eds. Endocrine Facets of Ageing: Novartis Foundation Symposium 242. Novartis Foundation Symposia. Chichester, UK: John Wiley & Sons, Ltd; 2002:125-142. doi:10.1002/0470846542.ch8. – Please contact the medical library for a copy.  Laron Z. Ethical issues in preventive intervention trials in relatives of IDDM. In: Theoretical and Practical Aspects of the Treatment of Diabetic Children. ; 1995:213- 214. – Please contact the medical library for a copy.  Laron Z. Ethical issues in preventive intervention trials in relatives of IDDM patients. Diabetes Prevention and Therapy IDIG Newsletter. 1993;7:3-4. – Please contact the medical library for a copy.  Laron Z. From Laron syndrome to primary IGF-I deficiency. Informer in Endocrinologia. 2004:7. – Please contact the medical library for a copy.  Laron Z. Global overview of psychosocial aspects of diabetes in youth. IDF Bulletin. 1991;36:13-14. – Please contact the medical library for a copy.  Laron Z. Global prevalence of type 2 diabetes in children and its health implications. Annales Nestle. 2005;63(1):1-9. – Please contact the medical library for a copy.  Laron Z. Glucose intolerance due to GH and IGF-I deficiency and oversecretion. (Abstract A53). Diabetes in the Young. 1994;30(2):PD-III-5. – Please contact the medical library for a copy.  Laron Z. Glucosuric Effect of Anabolic Steroids in Juvenile Diabetics. Helvetica Paediatrica Acta. 1965;20(6):635-642. – Please contact the medical library for a copy.  Laron Z. Growth hormone and IGF-I during and after exercise. Minerva Pediatrica. 2004;56(Suppl. 1):16-19. – Please contact the medical library for a copy.  Laron Z. Growth hormone and insulin-like growth factor-I: Effects on the brain. Chapter 14. In: Hormone/Behavior Relations of Clinical Importance: Endocrine Systems Interacting with Brain and Behavior. ; 2009:373-394. – Please contact the medical library for a copy.  Laron Z. Growth hormone and insulin-like growth factor-I: Effects on the brain. In: Hormones, Brain and Behavior. ; 2002:75-96. – Please contact the medical library for a copy.  Laron Z. Growth hormone insensitivity (Laron Syndrome). Reviews in Endocrine and Metabolic Disorders. 2002;3(4):347-355. – Please contact the medical library for a copy.  Laron Z. Growth hormone secretagogues. Clinical experience and therapeutic potential. Drugs. 1995;50(4):595-601. doi:10.2165/00003495-199550040-00002. – Please contact the medical library for a copy.  Laron Z. Growth Hormone Secretagogues: Future Therapies for Short Stature. Journal of Paediatrics and Child Health. 1997;33(Suppl 1):060. – Please contact the medical library for a copy.  Laron Z. Growth hormone, IGF-1 and diabetic retinopathy. (Abstract). Nutr Metab Dis. 2002;1(1):49. – Please contact the medical library for a copy.  Laron Z. Growth hormone, insulin-like growth factor I and diabetes mellitus. Childhood Diabetes Bailliere’s Clin Paediat. 1996;4(4):729-740. – Please contact the medical library for a copy.  Laron Z. Hormona de crecimiento y factor de crecimiento insulinoide tipo 1: ¿Benefician o perjudican el envejecimiento? Revista Española de Geriatría y Gerontología. 2006;41(3):147-149. doi:10.1016/S0211-139X(06)72944-4.  Laron Z. Human growth hormone (Editorial in Hebrew). Harefuah. 1965;69:240. – Please contact the medical library for a copy.  Laron Z. Hyperthyroidie: quel traitement? J d’Endocrinol Pediatr. 2000;3:75. – Please contact the medical library for a copy.  Laron Z. Hypoglycemia due to hormone deficiencies. Journal of Pediatric Endocrinology and Metabolism. 1998;11(SUPPL.1):117-120. – Please contact the medical library for a copy.  Laron Z. IGF-1 and insulin as growth hormones. In: Biology of IGF-1: Its Interaction with Insulin in Health and Malignant States. ; 2004:56-83. – Please contact the medical library for a copy.  Laron Z. IGF-I “The” or “A” growth hormone. (Abstract O-3). X International Congress of Auxology Human Growth in Sickness and in Health. 2004;Abstract B:18-19. – Please contact the medical library for a copy.  Laron Z. IGF-I: a growth hormone. J Clin Pathol: Mol Pathol. 2001;54(Abstract 27):45. – Please contact the medical library for a copy.  Laron Z. Immunological Aspects of Anterior Pituitary Hormones with Special Emphasis on Growth Hormone. In: Klein E, ed. Wachstumshormon Und Wachstumsstörungen Das Cushing-Syndrom. Berlin, Heidelberg: Springer Berlin Heidelberg; 1965:9-21. doi:10.1007/978-3-642-88683-6_2. – Please contact the medical library for a copy.  Laron Z. Incidence and Seasonality of Type 1 Diabetes Mellitus - What Now? Journal of Pediatric Endocrinology and Metabolism. 2002;15(5). doi:10.1515/JPEM.2002.15.5.573. – Please contact the medical library for a copy.  Laron Z. Increasing incidence of childhood obesity. Pediatric Endocrinology Reviews. 2004;1(SUPPL. 3):443-447. – Please contact the medical library for a copy.  Laron Z. Influence of GH and IGF-I on adipose tissue and carbohydrate metabolism. In: Laron Z, ed. Theoretical and Practical Aspects of the Treatment of Diabetic Children : 5th International ISPAD Course; Sesto Alta Val Pusteria (BZ), Dolomiti (Italy), March 11-18, 1995. Laron Z International Society for Pediatric and Adolescent Diabetes. Publisher: Editoriale Bios; 1995:163-166. – Please contact the medical library for a copy.  Laron Z. Insulin and the brain. Arch Physiol Biochem. 2009;115(2):112-116. doi:10.1080/13813450902949012.  Laron Z. Insulin–a growth hormone. Arch Physiol Biochem. 2008;114(1):11-16. doi:10.1080/13813450801928356. – Please contact the medical library for a copy.  Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. MP, Mol Pathol. 2001;54(5):311-316. doi:10.1136/mp.54.5.311  Laron Z. Insulin-like growth factor-I (IGF-I): Safety and efficacy. Pediatric Endocrinology Reviews. 2004;2(SUPPL. 1):78-85. – Please contact the medical library for a copy.  Laron Z. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity). Pediatric Endocrinology Reviews. 2008;5(3):766-771. – Please contact the medical library for a copy.  Laron Z. Interactions and effects of IGF-I on carbohydrate (CHO) and fat metabolism. In: Sociedad Dominicana de Endocrinologia y Nutricion. ; 1999:21. – Please contact the medical library for a copy.  Laron Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4-7. doi:10.1002/ajmg.10338. – Please contact the medical library for a copy.  Laron Z. Intranasally and orally active GH secretagogues are useful clinical tools: so why are they not on the market? J Endocrinol Invest. 2003;26(1):91-92. doi:10.1007/BF03345130  Laron Z. Is IGF-1 the real growth hormone? In: Nicoletti I, Schell LM, Gilli G, eds. Human Growth in Sickness and in Health : Plenary Lectures from the 10th International Congress of Auxology. Firenze: Nicomp; 2006:9-21. – Please contact the medical library for a copy.  Laron Z. Laron syndrome - Primary growth hormone resistance. In: Hormone Resistance Syndromes. Contemporary Endocrinology Vol. 2. ; 1999:17-37. – Please contact the medical library for a copy.  Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab. 2004;89(3):1031-1044. doi:10.1210/jc.2003-031033  Laron Z. Laron Syndrome : From description to therapy. Endocrinologist. 1993;3(1):21-28. doi:10.1097/00019616-199301000-00005. – Please contact the medical library for a copy.  Laron Z. Laron Syndrome: A new drug makes these so far untreatable dwarfed children grow? MINUSVAL. 1993;82(37). – Please contact the medical library for a copy.  Laron Z. Laron type dwarfism - A model of a genetic receptor disease. Nova Acta Leopoldina. 1992;67(281):309-315. – Please contact the medical library for a copy.  Laron Z. Laron-Typ Zwergwuchs - eine Rezeptorkrankheit (Abstract). Nova Acta Leopoldina. 1991;281:9-10. – Please contact the medical library for a copy.

 Laron Z. Laron-Type Dwarfism (Hereditary Somatomedin Deficiency): A Review. In: Frick P, Harnack GA, Kochsiek K, Martini GA, Prader A, eds. Ergebnisse Der Inneren Medizin Und Kinderheilkunde/Advances in Internal Medicine and Pediatrics. Berlin, Heidelberg: Springer Berlin Heidelberg; 1984:117-150. doi:10.1007/978-3-642- 69070-9_3. – Please contact the medical library for a copy.  Laron Z. Laron-type dwarfism (LTD): Past, present and future. Clinical Endocrinology Japanese. 1992;110(3): 1-7. – Please contact the medical library for a copy.  Laron Z. Laron-type dwarfism (LTD): Past, present and future. Current Medical Literature Growth and Growth Factors. 1991;6(4):99-102. – Please contact the medical library for a copy.  Laron Z. Lessons from Laron syndrome - a unique model to study the GH-IGF-I relationship. (Abstract #K26). Kongre Kitabi IX Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi. 2004:168-170. – Please contact the medical library for a copy.  Laron Z. Lessons from recent epidemiological studies in type 1 childhood diabetes. J Pediatr Endocrinol Metab. 1999;12 Suppl 3:733-736. – Please contact the medical library for a copy.  Laron Z. Metabolic consequences of early growth hormone and insulin-like growth factor-I deficiency. In: Boulten J, Laron Z, Rey J, eds. Long Term Consequences of Early Feeding. Proceeding. Philadelphia: Lippincott-Raven; 1996:225-236. – Please contact the medical library for a copy.  Laron Z. More on “diabetic control.” J Pediatr. 1978;92(2):340-341. doi:10.1016/S0022-3476(78)80044-4. – Please contact the medical library for a copy.  Laron Z. Multidisciplinary ambulatory care for diabetic children: reply. Diabetes Care. 1980;3(2):398. – Please contact the medical library for a copy.  Laron Z. Mutations along the GH axis - theoretical and practical aspects. (Abstract). Slov Pediatr. 2000;7:101. – Please contact the medical library for a copy.  Laron Z. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). Journal of Pediatric Endocrinology and Metabolism. 1999;12(SUPPL. 1):231-249. – Please contact the medical library for a copy.  Laron Z. Nicolae C. Paulescu - Scientist and politician. Israel Medical Association Journal. 2008;10(7):491-493.  Laron Z. Nicolae Constantin Paulescu: Mr. Hyde and Dr. Jekyll. 41st Annual Meeting of European Association for the Study of Diabetes (EASD). 2005:40. – Please contact the medical library for a copy.  Laron Z. Nutrition and diabetes. Nutrition and the Diabetic Child Pediatric & Adolescent Endocrinology. 1979;7:18-21. – Please contact the medical library for a copy.  Laron Z. One-year treatment with IGF-1 of children with Laron Syndrome. Clinical Courier. 1993;11:7-8. – Please contact the medical library for a copy.  Laron Z. Pediatric endocrinology and diabetology towards the new millennium. Expectations and limitations. Acta Biomedica de l’Ateneo Parmense. 2000;71(3- 4):121-124. – Please contact the medical library for a copy.  Laron Z. Pendrin et Syndrome de Pendred. J d’endocrinol Pediatr. 2004. – Please contact the medical library for a copy.  Laron Z. Pourquoi les enfants et les adolescents porteurs d’un diabete de type 1 naissentils a des saisons differentes des autres nouveau-nes? J d’Endocrinol Pediatr. 2001;12:1-2. – Please contact the medical library for a copy.  Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab. 1995;80(5):1526-1531. doi:10.1210/jcem.80.5.7744997. – Please contact the medical library for a copy.  Laron Z. Prolactinomes peripubertaires. J d’Endocrinol Pediatr. 2000;3:109. – Please contact the medical library for a copy.  Laron Z. Psychosocial problems of the diabetic child and adolescent: The basis for the need of a multidisciplinary team approach. In: Baba S, Kaneko T, eds. Diabetes, 1994 : Proceedings of the 15th International Diabetes Federation Congress, Kobe, 6- 11, November 1994. New York: Elsevier; 1995:832-836. – Please contact the medical library for a copy.  Laron Z. Psychosocial support to children and adolescents with diabetes. Pediatric Endocrinology Reviews. 2008;6(2):218-219. – Please contact the medical library for a copy.  Laron Z. Psychosoziale aspekte bei der behandlung des diabetes bei kindern und jugendlichen. Diabetes J. 1984;10:429-432. – Please contact the medical library for a copy.  Laron Z. Puberty. In: Dulbecco R, ed. Encyclopedia Human Biology. 2nd ed. ; 1997:295-300. – Please contact the medical library for a copy.  Laron Z. Puberty. In: Encyclopedia of Human Biology Vol 6. ; 1991:339-344. – Please contact the medical library for a copy.  Laron Z. Quo vadis childhood diabetes. J Clin Pathol: Mol Pathol. 2001;54(Abstract 26):45. – Please contact the medical library for a copy.  Laron Z. Response to European Journal of Endocrinology 1997 137 459-466 and 450- 452: Effect of GH on lipoprotein (A) in GH deficiency. European journal of endocrinology / European Federation of Endocrine Societies. 1998;138(4):440.  Laron Z. Safety of the insulin tolerance test (ITT). (eletter). Archives of Disease in Childhood. 2002:1-2.  Laron Z. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J. 2005;7(June):381-384.  Laron Z. Short stature due to genetic defects affecting growth hormone activity. N Engl J Med. 1996;334(7):463-466. doi:10.1056/NEJM199602153340711  Laron Z. Short-and Long-Term Growth Hormone Secretagogue Administration in Children. In: Growth Hormone Secretagogues in Clinical Practice. ; 1998:329-343. – Please contact the medical library for a copy.  Laron Z. Social and economic consequences of diabetic vasculopathy in children and adolescents. In: Diabetic Angiopathy in Children, B. Weber, Ed. Pediatric and Adolescent Endocrinology, Vol. 9. ; 1981:373-378. – Please contact the medical library for a copy.  Laron Z. Somatomedin, Insulin, Growth-Hormone and Growth - a Review. Israel Journal of Medical Sciences. 1982;18(8):823-829. – Please contact the medical library for a copy.  Laron Z. Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential. Drugs. 1993;45(1):1-8. doi:10.2165/00003495-199345010-00001. – Please contact the medical library for a copy.  Laron Z. Somatomedin-1 (recombinant insulin-like growth factor-1): clinical pharmacology and potential treatment of endocrine and metabolic disorders. BioDrugs. 1999;11(1):55-70. doi:10.2165/00063030-199911010-00006. – Please contact the medical library for a copy.  Laron Z. Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr J Med Sci. 1974;10(10):1247-1253. – Please contact the medical library for a copy.  Laron Z. Targets for the management of IDDM in children and adolescents. DIAMET. 1994;38:7-9. – Please contact the medical library for a copy.  Laron Z. Ten years of a metabolic-endocrinologic unit for children and adolescents. (Hebrew). Harefuah. 1968;75:117-118. – Please contact the medical library for a copy.  Laron Z. The clinical importance of IGF-I. Horm Res. 2000;53(Suppl. 2):105.  Laron Z. The diagnostic and prognostic importance of neonatal length measurements. Israel Medical Association Journal. 2000;2(2):84-85.  Laron Z. The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab. 1999;84(12):4397-4404. doi:10.1210/jcem.84.12.6255  Laron Z. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens). 2008;7(1):24-27.  Laron Z. The history and impact of the International Beilinson Symposia. Journal of Pediatric Endocrinology and Metabolism. 2001;14(SUPPL. 1):573-574. – Please contact the medical library for a copy.  Laron Z. The IGF-I-Somatostatin-insulin axis. Diabetes in the Young. 1992;(31):P29. – Please contact the medical library for a copy.  Laron Z. The importance of epidemiological studies. In: Theoretical and Practical Aspects of the Treatment of Diabetic Children. ; 1993:15-16. – Please contact the medical library for a copy.  Laron Z. The multidisciplinary team for children and adolescents with diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism. 2002;15(8):1109-1111. – Please contact the medical library for a copy.  Laron Z. The nomenclature of neonatal size - A conundrum. Pediatric Endocrinology Reviews. 2009;7(2):2. – Please contact the medical library for a copy.  Laron Z. The physiology and clinical application of IGF-I. In: An Update on Child Diabetes and Short Stature. ; 1993:113-120. – Please contact the medical library for a copy.  Laron Z. The role of education in the treatment of diabetic children. In: Theoretical and Practical Aspects of the Treatment of Diabetic Children : 5th International ISPAD Course; Sesto Alta Val Pusteria (BZ), Dolomiti (Italy), March 11-18, 1995. ; 1995:115- 118. – Please contact the medical library for a copy.  Laron Z. The role of growth hormone on fetal development in utero. Adv Exp Med Biol. 1972;27:391-398. doi:10.1007/978-1-4684-3219-0_32. – Please contact the medical library for a copy.  Laron Z. The syndrome of familial dwarfism and high plasma immunoreactive human growth hormone. Birth Defects Orig Artic Ser. 1974;10(4):231-238. – Please contact the medical library for a copy.  Laron Z. The use of anabolic steroids in the treatment of growth retardation. In: Somatic Growth of the Child. ; 1966:281-289. – Please contact the medical library for a copy.  Laron Z. Therapeutic Approach to Constitutional Delay of Growth and Puberty. In: Growth Disorders: The State of the Art. ; 1991:7-17. – Please contact the medical library for a copy.  Laron Z. Thoughts about future therapy of diabetes. (German). Diabetes/Hallo du Auch. 1984;4:3-4. – Please contact the medical library for a copy.  Laron Z. Type 2 diabetes mellitus in childhood--a global perspective. J Pediatr Endocrinol Metab. 2002;15 Suppl 1:459-469. – Please contact the medical library for a copy.  Laron Z. Usefulness of the Growth Hormone-Releasing Hormone Test Regardless of Which Fragment Is Used (Ghrh 1-44, 1-40 or 1-29). Israel Journal of Medical Sciences. 1991;27(6):343-345. – Please contact the medical library for a copy.  Laron Z. Utilisation systematique de l’echographie pour la detection du cancer de la thyroide chez l’enfant. (Commentary). J d’Endocrinol Pediatr. 2002:1. – Please contact the medical library for a copy.  Laron Z. Why only insulin - What is the role of IGF-I? Diabetes Prevention and Therapy IDIG Newsletter. 1991;5:13-14. – Please contact the medical library for a copy.  Laron Z. Withdrawal of human pituitary growth hormone. Lancet. 1985;325(8441):1324. doi:10.1016/S0140-6736(85)92808-9. – Please contact the medical library for a copy.  Laron ZV, Karp M, Modan M. The incidence of insulin-dependent diabetes mellitus in Israeli children and adolescents 0-20 years of age: a retrospective study, 1975-1980. Diabetes Care. 1985;8 Suppl 1:24-28. doi:10.2337/diacare.8.1.s24  Laron Z. GH-S Growth hormone secretagogues. (in Hebrew). Pediatric Update. 1998;24:4-10. – Please contact the medical library for a copy.  Laron Z, Anin S, Klinger B. Effectiveness of IGF-I in Long Term Treatment of Adult Laron Syndrome Patients. Proceedings of the 75th Annual Meeting of the Endocrine Society. 1993;(Abstract 1598):450. – Please contact the medical library for a copy.

 Laron Z, Avitur, Klinger B. Carbohydrate metabolism in primary GH resistance (Laron syndrome) before and during IGF-1 treatment. Metabolis.1995;44(10, supp.4):113- 118.  Laron Ζ, Ginsberg S. Both longstanding IGF-I deficiency and long-term IGF-I treatment cause marked obesity and hyperlipidemia (Abstract). Annual Meeting of the Israeli Clinical Pediatric Society. 2010;Abstract B:30. – Please contact the medical library for a copy.  Laron Z, Hampe C, Kordomouri O, Kordomouri O, Haberland H, Landin-Olsson N, Torn C, Lewy H. Diabetic children with several or high GAD65 antibodies have a different seasonality of month of birth than no or low antibody populations. (Abstract #016). Pediatr Diabetes. 2006;7(Suppl. 5):63. – Please contact the medical library for a copy.  Laron Ζ, Iluz M. Effect of IGF-I on brain growth as measured by head circumference in IGF-I deficient and IGF-I treated patients with Laron syndrome (Abstract P2-d3- 772). Horm Res Paediatr. 2010;74(3):230. – Please contact the medical library for a copy.  Laron Z, Karp M, Pertzelan R, Kauli R, Keret R, Doron M. The syndrome of familial dwarfism and high plasma immunoreactive human growth hormone (IR-HGH). In: Growth and Growth Hormone : Proceedings. ; 1972:458-482. – Please contact the medical library for a copy.  Laron Ζ, Kauli R. Gender differences in Laron syndrome - A model of congenital GH/IGF-I deficiency. (Abstract). Gender Medicine. 2010;7(5:15.10):504. – Please contact the medical library for a copy.  Laron Z, Klinger B, Erster B, Aurbach Y. Hypoglycaemia Effect of IGF-I. Abstracts for the ISDG 17th Annual Meeting. 1991;26:15-16. – Please contact the medical library for a copy.  Laron Z, Korenreich L, Hershkowitz I. Did the small-bodied hominis from Flores (Indonesia) suffer from Laron syndrome? (Abstract #P3-202). 88th Annual Meeting of the Endocrine Society Program & Abstract Book. 2006:688. – Please contact the medical library for a copy.  Laron Z, Koivisto V, Blub W, Karasik A, Silbergeld A. IGF-binding proteins in untreated and IGF-I treated patients with Laron Syndrome. In: Laron Z, Parks J S (eds.) Lessons from Laron syndrome (LS) 1966-1992. 1993;24:174-180. – Please contact the medical library for a copy.  Laron Z, Parks J s. First direct evidence for a GH receptor defect in patients with Laron Syndrome. Lessons from Laron Syndrome (LS), 1966-1992, Pediat Adolesc Endocrinol. 1993;24:1-3. – Please contact the medical library for a copy.

 Laron Ζ, Shevah O. Hereditary aspects of Laron syndrome (primary growth hormone insensitivity) - a study of the Israeli cohort (Abstract #P-57). Growth Horm & IGF-I Res. 2006;16(Suppl B):S35. – Please contact the medical library for a copy.  Laron Ζ, Waisman N, Webb M. Despite severe obesity only some patients with Laron syndrome (LS) have fatty liver (Abstract #PO3-569). Horm Res. 2007;68(Suppl. 1):176-177.  Laron Ζ, Weinberger D. Diabetes mellitus and its vascular complications in patients with congenital IGF-I deficiency. 3rd Russell Berrie D-Cure Symposium, Diabetes and Obesity. 2007;Abstract #:54. – Please contact the medical library for a copy.  Laron, Ben-dan I, Shrem M, Dickerman Z, Lilos P. Puberty in simple obese boys and girls. In: Cacciari E, Laron Z, Raiti S, eds. Obesity in Childhood. London: Academic Press; 1978:29-40. – Please contact the medical library for a copy.  Laron, Butenandt O. Psycological well-being of young adults with growth hormone deficiency before and after hGH treatment. In: Zvi Laron OB, ed. Growth Hormone Replacement Therapy in Adults : Pros and Cons. London: London : Freund Pub. House, c1993.; 1993:115-122. – Please contact the medical library for a copy.  Laron, Kauli R. Diabetes insipidus. In: Gellis S, ed. Current Pediatric Therapy. 8. [ed.]. Philad.: Saunders; 1978:342-344. – Please contact the medical library for a copy.  Laron, Lazar L, Klinger B. 12. In: Castells S, Castells S, Wisniewski KE, eds. Growth Hormone Treatment in Down’s Syndrome. ; 1993:151-161. – Please contact the medical library for a copy.

 Laron Z, Korenreich L, Hershkowitz I. Did the small-bodied Hominins from Flores (Indonesia) suffer from Laron syndrome? (Abstract #P73). Annual Meeting of the Israel Endocrine Society. 2006;Abstract b. – Please contact the medical library for a copy.  Laron. Etiology of various types of pituitary dwarfism in children. In: Growth and Growth Factors : Proceedings of the International Symposium on Growth and Growth Factors, Held June 4 and 5, 1979. ; 1980:31-56. – Please contact the medical library for a copy.  Laron-Kenet T, Shamis I, Weitzman S, Rosen S, Laron ZV. Mortality of patients with childhood onset (0-17 years) Type I diabetes in Israel: a population-based study. Diabetologia. 2001;44 Suppl 3:B81-6. doi:10.1007/pl00002959  Lazar L, Kauli R, Bruchis S, J N, Laron Z, Pertzelan A. HYPERANDROGENISM AS A CAUSE OF EARLY POLYCYSTIC OVARY SYNDROME (PCOS) IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY (CPP). Pediatric Research. 1993;33(SUPPL. 14):Abstract 64.  Lazar L, Kauli R, Gidali A, J N, Laron Z. Abnormal adrenal responseto ACTH in boys with idiopathic central precocious puberty (ICPP). Horm Res. 1994;41(Abstract 189):104. – Please contact the medical library for a copy.  Lazar l, Pertzelan A, L aron Z. Effect of hGH treatment on head (brain) growth in children with isolated GH deficiency. Horm Res.1992;38 (S4):20. – Please contact the medical library for a copy.  Leibovici L, Samra Z, Konisberger H, Kalter-Leibovici O, Pitlik SD, Drucker M. Bacteremia in adult diabetic patients. Diabetes Care. 1991;14(2):89-94. doi:10.2337/diacare.14.2.89  Lerman-Sagie T, Merlob P, Shuper A, et al. New findings in a patient with Dubowitz syndrome: velopharyngeal insufficiency and hypoparathyroidism. Am J Med Genet. 1990;37(2):241-243. doi:10.1002/ajmg.1320370215. – Please contact the medical library for a copy.  Lev-Ran A, Hwang DL, Miller JD, Josefsberg Z. Excretion of epidermal growth factor (EGF) in diabetes. Clin Chim Acta. 1990;192(3):201-206. doi:10.1016/0009- 8981(90)90222-e. – Please contact the medical library for a copy.  Levy-marchal C, (editor) RC. Epidemiology And Etiology Of Insulin-Dependent Diabetes In The Young: Symposium, Paris, May 1991 (Pediatric And Adolescent Endocrinology, Vol. 21). Vol 21. 1st ed. (Levymarchal C, Czernichow P, eds.). Basel: S. Karger; 1992:242. – Please contact the medical library for a copy.  Lewinger Z, Kauli R, Galatzer A, Laron Z. Congenital Hypothyroidism Due to Athyreosis (Hebrew). Harefuah. 1983;105(7):149-151. – Please contact the medical library for a copy.  Lewy H, Hampe CS, Kordonouri O, et al. Seasonality of month of birth differs between type 1 diabetes patients with pronounced beta-cell autoimmunity and individuals with lesser or no beta-cell autoimmunity. Pediatr Diabetes. 2008;9(1):46- 52. doi:10.1111/j.1399-5448.2007.00265.x  Lewy H, Laron Z. Month of birth of children with type I diabetes differs from total live birth also in the US. (Abstract). In: 20th Meeting of the Israel Diabetes Association. ; 2003:31. – Please contact the medical library for a copy.  Lewy H, Laron Ζ. Gender differences in the month of birth seasonality in childhood- onset autoimmune diseases. Gender Medicine2. 2010;7(5:12.50):489. – Please contact the medical library for a copy.  Lewy H, Meirson H, Laron Z. Seasonality of birth month of children with celiac disease differs from that in the general population and between sexes and is linked to family history and environmental factors. J Pediatr Gastroenterol Nutr. 2009;48(2):181-185. doi:10.1097/MPG.0b013e3181709530. – Please contact the medical library for a copy.  Lewy H, Rotstein A, Kahana E, Marrosu MG, Cocco E, Laron Z. Juvenile multiple sclerosis similar to type I diabetes mellitus has a seasonality of month of birth which differs from that in the general population. J Pediatr Endocrinol Metab. 2008;21(5):473-477. doi:10.1515/jpem.2008.21.5.473. – Please contact the medical library for a copy.  Liberman UA, Samuel R, Halabe A, et al. End-organ resistance to 1,25- dihydroxycholecalciferol. Lancet. 1980;1(8167):504-506. doi:10.1016/s0140- 6736(80)92763-4. – Please contact the medical library for a copy.  Kauli R, Kornreich L, Laron Z. Final Outcome in Girls with Precoclious Puberty Treated with the GNRH Agonist-TRP(6)-LHRH. The Basic Science Of Gnrh Analogues (Advances In The Study Of Gnrh Analogues) (v. 2). (Lunenfeld B, ed.). Parthenon Pub Group; 1990:147-156. – Please contact the medical library for a copy.  Lurie R, Ben-Amitai D, Laron Z. Impaired hair growth and structural defects in patients with Laron syndrome (primary IGF-I deficiency). The Journal of Investigative Dermatology. 2001:Abstract 144. – Please contact the medical library for a copy.  Lurie R, Ben-Amitai D, Laron Z. Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatology (Basel). 2004;208(4):314-318. doi:10.1159/000077839  Manor R, Dickerman Z, Laron Z. Myopia during bromocriptine treatment. (Letter). Lancet. 1981;(I):102. – Please contact the medical library for a copy.  Maor G, Laron Z, Eshet R, Silbermann M. The early postnatal development of the murine mandibular condyle is regulated by endogenous insulin-like growth factor-I. J Endocrinol. 1993;137(1):21-26. doi:10.1677/joe.0.1370021. – Please contact the medical library for a copy.  Maor G, Silbermann M, von der Mark K, Heingard D, Laron Z. Insulin enhances the growth of cartilage in organ and tissue cultures of mouse neonatal mandibular condyle. Calcif Tissue Int. 1993;52(4):291-299. doi:10.1007/bf00296654. – Please contact the medical library for a copy.  Marilus R, Dickerman Z, Kaufman H, Varsano I, Laron Z. Addison’s disease associated with precocious sexual development in a boy. Acta Paediatr Scand. 1981;70(4):587- 589. doi:10.1111/j.1651-2227.1981.tb05748.x. – Please contact the medical library for a copy.  Meacham LR, Brown MR, Murphy TL, et al. Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron’s syndrome. J Clin Endocrinol Metab. 1993;77(5):1379-1383. doi:10.1210/jcem.77.5.8077336. – Please contact the medical library for a copy.  MEACHAM LRB MR; Murphy, TC; Keret R, Klinger B, Laron Z. Deletions within the growth hormone receptor gene. Acta Paediatrica. 1992;383:145-146. – Please contact the medical library for a copy.  Mikulecký M, Laron Z, Lewy H. Birth seasonality in diabetic adults: Reevaluation according to the age at disease onset (multiple letters) [3]. Israel Medical Association Journal. 2004;6(10):647-648. – Please contact the medical library for a copy.  Mimouni M, Asherov J, Dickerman Z, Kaufman H, Laron Z. Plasma gonadotropins, sex hormones and fertility among juvenile diabetics. In: Progress in Medico-Social Problems in Juvenile Diabetics. Pediatric & Adolescent Endocrinology Vol. 11. ; 1983:30-37. – Please contact the medical library for a copy.  Mimouni M, Galatzer A, Madanes L, Lew E, Doron M, Laron Z. A study of the reliability of the Eyetone and reflectance meter in instant blood glucose determinations. Acta Paediatrica Belgica. 1978;31(1):50-53. – Please contact the medical library for a copy.  Mimouni M, Galatzer A, Madanes L, Lew E, Doron M, Laron Z. Reliability of the Eyetone instrument and the Reflectance Meter in instant blood glucose determinations. Isr J Med Sci. 1978;14(3):319-323. – Please contact the medical library for a copy.  Mimouni M, Kaufman H, Roitman A, Morag C, Sadan N. Hypertension in a neonate with 11 beta-hydroxylase deficiency. Eur J Pediatr. 1985;143(3):231-233. doi:10.1007/bf00442149. – Please contact the medical library for a copy.  Mimouni M, Koivukangas T, Karp M, Laron Z. Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children. Acta Diabetol Lat. 1979;16(1):63-66. doi:10.1007/BF02590764. – Please contact the medical library for a copy.  Mimouni M, Lew E, Madanes L, Laron Z. Comparison Between Reflomat Reflectance Meter and Autoanalyzer for Instant Blood-Sugar Measurements. Israel Journal of Medical Sciences. 1978;14(9):990-991. – Please contact the medical library for a copy.  Mimouni M, Sarnat H, Faiman G, Galatzer A, Karp M, Laron Z. Is there a correlation between diet and control in juvenile diabetes mellitus? Nutrition and the Diabetic Child Pediatric & Adolescent Endocrinology. 1979;7:89-93. – Please contact the medical library for a copy.  Modan M, Karp M, Bauman B, Gordon O, Danon YL, Laron Z. Mortality in Israeli Jewish patients with type 1 (insulin-dependent) diabetes mellitus diagnosed prior to 18 years of age: a population based study. Diabetologia. 1991;34(7):515-520. doi:10.1007/bf00403289  Moshe Karp AG S Amir, Z Laron. How we teach Diabetes in Israel: Educating Children and Young Adults with Type I Diabetes. 1992;37:22-23. – Please contact the medical library for a copy.  Mullis PE, Eblé A, Wagner JK, Holl RW, Silbergeld A, Laron Z. Effect of different serum concentrations of growth hormone-binding protein (GHBP) on the regulation of GH receptor/GHBP gene transcription in a human hepatoma cell line. Hormone Research. 1997;47(2):73-80. – Please contact the medical library for a copy.  Mullis PE, Wagner JK, Eble A, Holl RW, Silbergeld A, Laron Z. Regulation of growth hormone (GH)-receptor/GH-binding protein (GHBP) gene transcription by GHBP (Abstract #477). Horm Res. 1996;46(Suppl. 2):120. – Please contact the medical library for a copy.  Neu A, Kehrer M, Ashkenazi I, Laron Z. Seasonality of birth in children (0-14 years) with diabetes mellitus type 1 in Baden-Wuerttemberg, Germany. J Pediatr Endocrinol Metab. 2000;13(8):1081-1085. doi:10.1515/jpem.2000.13.8.1081. – Please contact the medical library for a copy.  Nevo Z, Laron Z. Growth factors. Am J Dis Child. 1979;133(4):419-428. doi:10.1001/archpedi.1979.02130040073016. – Please contact the medical library for a copy.  Nevo Z, Laron Z. Hormonal and local agents as extracellular regulators of cartilage growth measured by the rate of proteoglycan synthesis. A hypothesis. Med Hypotheses. 1980;6(4):431-436. doi:10.1016/0306-9877(80)90057-2. – Please contact the medical library for a copy.  Nevo Z, Silbergeld AK, Mamet R. The effect of normal human serum on proteoglycan synthesis. Biochem Biophys Acta. 1978;541:76-83. – Please contact the medical library for a copy.  Nissenkorn I, Yassur Y, Gilad E, Laron Z, Kauli R, Ben-Sira I. Keropathy associated with hypoparathyroidism and Addison’s disease. J Pediat Ophthalmol Strab. 1981;18(2):28-30. – Please contact the medical library for a copy.  Orit S, Joanne Y, Meira Z, Hannah T, Zvi L. IGF-I treatment of patients with Laron syndrome suppresses serum thrombopoietin levels but does not affect serum erythropoietin. Am J Hematol. 2009;84(1):64-64. doi:10.1002/ajh.21318. – Please contact the medical library for a copy.  Patterson CC, Dahlquist G, Soltész G, Green A, EURODIAB ACE Study Group. Europe and Diabetes. Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia. 2001;44 Suppl 3:B9- 16. doi:10.1007/pl00002961  Pertzelan A, Adam A, Laron Z. Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. Isr J Med Sci. 1968;4(4):895-900. – Please contact the medical library for a copy.  Pertzelan A, Adler-Bier M, Kauli R, et al. Linear growth in hypopituitary patients treated with hGH after age fifteen. Acta Paediatr Scand Suppl. 1979;277:69-74. – Please contact the medical library for a copy.  Pertzelan A, Bauman B, Gurewitz R, Matz S, Silbergeld A, Laron Z. Prolactin secreting pituitary adenoma in childhood and adolescence. In: Advances in Pituitary Adenoma Research. Advances in the Biosciences Vol. 69. Pergamon Press; 1988:303-307. – Please contact the medical library for a copy.  Pertzelan A, Blum I, Grunebaum M, Laron Z. The combined effect of growth hormone and methandrostenolone on the linear growth of patients with multiple pituitary hormone deficiencies. Clin Endocrinol (Oxf). 1977;6(4):271-276. doi:10.1111/j.1365-2265.1977.tb02011.x. – Please contact the medical library for a copy.  Pertzelan A, Doron M, Assa S, Keret R, Laron Z. [Effect of somatostatin in patients with high plasma growth hormone]. Harefuah. 1977;93(3-4):74-76. – Please contact the medical library for a copy.  Pertzelan A, Kauli R, Assa S, Greenberg D, Laron Z. Intermittent treatment with human growth hormone (GH) in isolated GH deficiency and in multiple pituitary hormone deficiencies. Clin Endocrinol (Oxf). 1976;5(1):15-24. doi:10.1111/j.1365- 2265.1976.tb03799.x. – Please contact the medical library for a copy.  Pertzelan A, Kauli R, Zadik Z, Blum I, Laron Z. Puberty in patients with growth hormone deficiency. In: Auxology — Human Growth in Health and Disorder. ; 1978:101-108. – Please contact the medical library for a copy.  Pertzelan A, Keret R, Bauman B, et al. Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies. Horm Res. 1985;22(1-2):24-31. doi:10.1159/000180068. – Please contact the medical library for a copy.  Pertzelan A, Kowadlo-silbergeld A, Mameat R, Nevo Z, Laron Z. The clinical application of serum somatomedin activity determination. Harefuah. 1979;96:519- 521. – Please contact the medical library for a copy.  Pertzelan A, Laron Z, Adler-Bier M, Prager-Lewin R, Kaufman H. Gonadotrophin release in untreated congenital virilising adrenal hyperplasia. Arch Dis Child. 1978;53(4):305-307. doi:10.1136/adc.53.4.305  Pertzelan A, Lazar L, Klinger B, Laron Ζ. Puberty in Fifteen Patients with Laron Syndrome: A Longitudinal Study. In: Lessons from Laron Syndrome (LS), 1966-1992, Pediat. Adolesc. Endocrinol. ; 1993:27-33. – Please contact the medical library for a copy.  Pinto EM MD Laron Z, Damiani D, Lins TSS, Shevah O, Otto P, Mendonca BB, Arnhold IJP, Jorge AAL. Founder effect of E180splice mutation in GHR gene from Brazilian and Moroccan families with Laron syndrome (Abstract #.P2-556). 90th Annual Meeting of the American Endocrine Society. 2008;Program an:537. – Please contact the medical library for a copy.  Posner B, Josefsberg Ζ, Bergeron JJM. Intracellular insulin receptors: identification and regulation in normal and obese rodents. In: Nutrition and the Diabetic Child. Pediatric & Adolescent Endocrinology Vol. 7. ; 1979:382-390. – Please contact the medical library for a copy.  Posner B, Josefsberg Ζ, Bergeron JJM. Polypeptide hormone receptors: recent studies on localization, regulation and internalization. Clinical Neuroendocrinology: A pathophysiological approach. 1979:173-181. – Please contact the medical library for a copy.  Posner BI, Josefsberg Z, Bergerson JJ. Intracellular polypeptide hormone receptors. Characterization and induction of lactogen receptors in the Golgi apparatus of rat liver. J Biol Chem. 1979;254(24):12494-12499.  Presentations O. IGF-I administration stimulates linear growth in children with Laron type dwarfism. (Abstract 45). Hormone Res. 1992;38(Suppl. 4):Abstract 45. – Please contact the medical library for a copy.  Ramot Y, Josefsberg Ζ, Pertzelan A, Orbach Y, Laron Z. Criteria for evaluation of treatment in primary hypothyroidism in children. Harefuah. 1981;100:263-265. – Please contact the medical library for a copy.  Roche EF, Lewy H, Hoey HMCV, Laron Z. Differences between males and females in the seasonality of birth and month of clinical onset of disease in children with type 1 diabetes mellitus in Ireland. J Pediatr Endocrinol Metab. 2003;16(5):779-782. doi:10.1515/jpem.2003.16.5.779. – Please contact the medical library for a copy.  Roitman A, Assa S, Kauli R, Laron Z. Prolactin deficiency, obesity, and enlarged testes--a new syndrome? Arch Dis Child. 1980;55(8):647-649. doi:10.1136/adc.55.8.647  Roitman A, Assa S, Pertzelan A, Zadik Z, Laron Z. Prolactin secretion in 70 patients with growth hormone deficiency. Eur J Pediatr. 1980;133(3):251-258. doi:10.1007/bf00496085. – Please contact the medical library for a copy.  Roitman A, Bruchis S, Bauman B, Kaufman H, Laron Z. Total deficiency of corticosteroid-binding globulin. Clin Endocrinol (Oxf). 1984;21(5):541-548. doi:10.1111/j.1365-2265.1984.tb01393.x. – Please contact the medical library for a copy.  Roitman A, Laron Z. Hypothalamo-pituitary hormone insufficiency associated with cleft lip and palate. Arch Dis Child. 1978;53(12):952-955. doi:10.1136/adc.53.12.952  Roitman A, Pertzelan A, Laron Z. Cleft palate and pituitary insufficiency. Harefuah. 1977;92:139. – Please contact the medical library for a copy.  Rotstein A, Lewy H, Kahana E, Marrosu MG, Cocco E, Laron Z. Abnormal seasonality of month of birth in multiple sclerosis patients. The Seventh Research Fair of The Sackler Faculty of Medicine, Tel Aviv University. 2006;Abstract B(S-23):250. – Please contact the medical library for a copy.  Sarnat H, Mimouni M, Amir E, et al. Dental status of diabetic children in relation to diet and degree of diabetic control. In: Nutrition and the Diabetic Child. Pediatric & Adolescent Endocrinology Vol. 7. ; 1979:347-351. – Please contact the medical library for a copy.  Sarne Y, Gil-Ad I, Laron Z. Regulation of hypophysial secretion by endogenous opiates: Humoral endorphin stimulates the release of growth hormone. Life Sci. 1981;28(6):681-686. doi:10.1016/0024-3205(81)90133-8. – Please contact the medical library for a copy.  Scheinowitz M, Feinberg MS, Laron Z. IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function. Growth Horm IGF Res. 2009;19(3):280-282. doi:10.1016/j.ghir.2008.11.004  Schindel B, Ashkenazi I, Keret R, et al. Effect of octreotide on 24-hour growth hormone and prolactin secretory patterns in acromegalics. Horm Res. 1991;36(5- 6):209-215. doi:10.1159/000182164. – Please contact the medical library for a copy.  Schottenfeld-Naor Y, Galatzer A, Karp M, Josefsberg Z, Laron Z. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. Isr J Med Sci. 1985;21(10):822-828. – Please contact the medical library for a copy.  Sella T, Shoshan A, Goren I, et al. A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000-2008. Diabet Med. 2011;28(1):48-53. doi:10.1111/j.1464- 5491.2010.03174.x.  Sex Differences in the Mortality Associated with Insulin-dependent Diabetes Mellitus in Four CountriesThe Diabetes Epidemiology Research International (DERI) Study. Am J Epidemiol. March 1991. doi:10.1093/oxfordjournals.aje.a115929. – Please contact the medical library for a copy.  Shaklai M, Aderka D, Blum I, et al. Suppression of Hypoglycemic Attacks and Insulin Release By Propranolol in a Patient With Metastatic Malignant Insulinoma. Diabetes & Metabolism. 1977;3(3):155-158. – Please contact the medical library for a copy.  Shamis I, Gordon O, Albag Y, Goldsand G, Laron Z. Ethnic differences in the incidence of childhood IDDM in Israel (1965-1993). Marked increase since 1985, especially in Yemenite Jews. Diabetes Care. 1997;20(4):504-508. doi:10.2337/diacare.20.4.504  Shamis I, Gordon O, Albag Y, Laron Z. High and Rapidly Increasing Incidence of Childhood IDDM in Yemenite Jews (1980 - 1993). Israel J Med Sci. 1997;33(1):Suppl. 1: S-12. – Please contact the medical library for a copy.  Shechter M, Ginsberg S, Scheinowitz M, Feinberg MS, Laron Z. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function. Growth Horm IGF Res. 2007;17(2):165-170. doi:10.1016/j.ghir.2007.01.009  Shehadeh N, Shamis I, Laron Z. Seasonal variation of IDDM in Israel: The role of vitamin D? Diabetes, Nutrition and Metabolism - Clinical and Experimental. 1997;10(1):39-40. – Please contact the medical library for a copy.  Shevah O YJ Zoldan M, Tamari H, Laron Z. IGF-I treatment of patients with Laron syndrome suppresses thrombopoietin levels but does not affect erythropoietin (Abstract #G-18). The 8th Research Fair of the Sackler Faculty of Medicine. 2008;Abstract B:181. – Please contact the medical library for a copy.  Shevah O, Borrelli P, Rubinstein M, Laron Z. A new mutation in the human growth hormone receptor gene. Annual Meeting of the Israel Endocrine Society. 2001;Abstract B:P50. – Please contact the medical library for a copy.  Shevah O, Borrelli P, Rubinstein M, Laron Z. Identification of two novel mutations in the human growth hormone receptor gene. J Endocrinol Invest. 2003;26(7):604-608. doi:10.1007/BF03347015  Shevah O, Galatzer A, Kornreich L, Laron Z. Correlation between intellectual capacity and variability of the growth hormone receptor defect in patients with Laron syndrome (LS). Abstract G-8. The Sixth Research Fair of The Sackler Faculty of Medicine. 2005;Abstract B:101. – Please contact the medical library for a copy.  Shevah O, Galatzer A, Kornreich L, Laron Z. The intellectual capacity of patients with Laron syndrome (LS) differs with various molecular defects of the growth hormone receptor gene. (Abstract #A27). Annual Meeting of the Israel Endocrine Society. 2004;Abstract B:A27. – Please contact the medical library for a copy.  Shevah O, Galatzer A, Kornreich L, Laron Z. The intellectual capacity of patients with Laron syndrome (LS) differs with various molecular defects of the growth hormone receptor gene. (Abstract #P2-362). Horm Res. 2004;62(Suppl. 2):102. – Please contact the medical library for a copy.  Shevah O, Galli-Tsinopoulou A, Rubinstein M, Nousia-Arvanitakis S, Laron Z. Classical phenotype of Laron syndrome in a girl with a heterozygous mutation and heterozygous polymorphism of the growth hormone receptor gene. J Pediatr Endocrinol Metab. 2004;17(3):371-374. doi:10.1515/jpem.2004.17.3.371. – Please contact the medical library for a copy.  Shevah O, Kornreich L, Galatzer A, Laron Z. The intellectual capacity of patients with Laron syndrome (LS) differs with various molecular defects of the growth hormone receptor gene. Correlation with CNS abnormalities. Horm Metab Res. 2005;37(12):757-760. doi:10.1055/s-2005-921097. – Please contact the medical library for a copy.  Shevah O, Laron Z, Rubinstein M. Growth hormone receptor mutations that interfere with signal transduction: Study of the Israeli cohort of patients with Laron syndrome. (Abstract #P-12). Signal Transduction in Health and Disease (STADY). 2002:80. – Please contact the medical library for a copy.  Shevah O, Laron Z. Did the small-bodied hominins from Flores (Indonesia) suffer from Laron syndrome? The Seventh Research Fair of The Sackler Faculty of Medicine, Tel Aviv University. 2006;Abstract B(G-16):110. – Please contact the medical library for a copy.  Shevah O, Laron Z. Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron Syndrome. Pediatric Endocrinology Reviews. 2006;3(SUPPL. 3):489-497. – Please contact the medical library for a copy.  Shevah O, Laron Z. Hereditary aspects of Laron syndrome (primary growth hormone insensitivity) - a study of the Israeli cohort. The Seventh Research Fair of The Sackler Faculty of Medicine, Tel Aviv University. 2006;Abstract B(G-15):109. – Please contact the medical library for a copy.  Shevah O, Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res. 2007;17(1):54-57. doi:10.1016/j.ghir.2006.10.007  Shevah O, Laron Ζ. IGF-I deficient patients seem protected from cancer not so their heterozygotes first-degree family members (Abstract #P2-298) . 88th Annual Meeting of the Endocrine Society Program & Abstracts Book. 2006:470. – Please contact the medical library for a copy.  Shevah O, Laron Ζ. IGF-I deficient patients seem protected from cancer not so their heterozygotes first-degree family members (Abstract #A24). Annual Meeting of the Israel Endocrine Society. 2006;Abstract B. – Please contact the medical library for a copy.  Shevah O, Nunez O, Rubinstein M, Laron Z. Intronic mutation in the growth hormone receptor gene in a Peruvian girl with Laron syndrome. Journal of Pediatric Endocrinology and Metabolism. 2002;15(7):1039-1040. – Please contact the medical library for a copy.  Shevah O, Rubinstein M, Laron Z, Tiqva P. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron Syndrome patients in Israel: relationship between defects and ethnic groups. Isr Med Assoc J. 2004;6(October):630-633.  Shevah O, Rubinstein M, Laron Z. Molecular defects in the growth hormone receptor of Laron syndrome patients studied in Israel. (Abstract #K-4). Tel Aviv University Research Fair, Abstract Book. 2003:166. – Please contact the medical library for a copy.  Shevah O, Rubinstein M, Laron Z. Molecular etiology of Laron syndrome (LS) patients from different ethnic groups studied in Israel: new and old molecular defects. (Abstract # P82). Annual Meeting of the Israel Endocrine Society. 2003:Abstract #P82. – Please contact the medical library for a copy.  Shevah O, Rubinstein M, Laron Z. Molecular etiology of Laron syndrome patients from different ethnic groups studied in Israel: New and old molecular defects. (Abstract .#P1-150). Hormone Research in Paediatrics. 2003;60(Suppl. 2):43-44. – Please contact the medical library for a copy.  Shevah O, Yacobovich J, Zoldan M, Tamar H, Laron Z. IGF-I treatment of patients with Laron syndrome suppresses thrombopoietin levels but does not affect erythropoietin (Abstract #P-73). GH and IGF Res. 2008;18(Suppl. 1):S48. – Please contact the medical library for a copy.  Shofar A, Laron Z. Development of precocious puberty in a boy with primary hypothyroidism inadequately treated. Harefuah. 1978;95:335-337. – Please contact the medical library for a copy.  Shulman LM, Hampe CS, Ben-Haroush A, et al. Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study. Diabet Med. 2014;31(6):681-685. doi:10.1111/dme.12404  Shurka E, Galatzer A, Baizerman M. The self-concept of growth retarded children, adolescents, and youth: An exploratory study. Journal of Integrative & Eclectic Psychotherapy. 1983;2(3):21-35. – Please contact the medical library for a copy.  Shurka E, Laron Z. [Rehabilitation of children and adolescents with growth retardation]. Harefuah. 1975;89(3):112-114. – Please contact the medical library for a copy.  Shurka E, Laron Z. Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. Isr J Med Sci. 1975;11(4):352-357. – Please contact the medical library for a copy.  Shurka E, Laron Z. Adjustment and rehabilitation problems of children and adolescents with growth retardation. III. Bone diseases. Case presentations. Acta Medica Auxologica. 1976;8(3):215-221. – Please contact the medical library for a copy.  Silbergeld A, Dastot F, Klinger B, et al. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: Extended phenotypic study in a very large pedigree. Journal of Pediatric Endocrinology and Metabolism. 1997;10(3):265-274. – Please contact the medical library for a copy.  Silbergeld A, Keret R, Selman-Almonte A, Klinger B, Laron Z. Serum Growth Hormone Binding Protein in Laron Syndrome Patients and Their Relatives. In: Lessons from Laron Syndrome (LS) 1966-1992 : Pediat. Adolesc. Endocrinol Vol. 24. ; 1993:153- 159. – Please contact the medical library for a copy.  Silbergeld A, Klinger B, Anin S, Eshet R, Laron Z. Supranormal levels of serum GHBP, elevated GH and normal IGF-I in family members of a girl with Laron syndrome (LS). (Abstract #178). Horm Res. 1996;46(Suppl. 2):45. – Please contact the medical library for a copy.  Silbergeld A, Klinger B, Eshet R, Keret R, Laron Z. Serum growth hormone binding protein (GHBP) is decreased by exogenous IGF-I in GHBP-positive Laron Syndrome (LS). Horm Res. 1994;41(Abstract 114):85. – Please contact the medical library for a copy.  Silbergeld A, Klinger B, Keret R, Eshet R, Almonté AS, Laron Z. Serum growth hormone-binding protein (GHBP) activity is decreased by administration of insulin- like growth factor I in three Laron syndrome siblings with normal GHBP. Proc Soc Exp Biol Med. 1994;206(3):324-327. doi:10.3181/00379727-206-43769. – Please contact the medical library for a copy.  Silbergeld A, Klinger B, Schwartz H, Laron Z. Serum prolactin in patients with Laron- type dwarfism: effect of insulin-like growth factor I. Horm Res. 1992;37(4-5):160- 164. – Please contact the medical library for a copy.  Silbergeld A, Klinger B, Schwartz H, Laron Z. Serum Prolactin in Laron Syndrome: Effect of Insulin-like growth factor 1. PEDIATRIC AND ADOLESCENT ENDOCRINOLOGY. 1993;24:261-266. – Please contact the medical library for a copy.  Silbergeld A, Lilos P, Laron Z. Catch-up growth in foot length, height and head circumference in children with Laron syndrome treated with IGF-1. (Abstract #P73). Annual Meeting of the Israel Endocrine Society. 2004;Abstract B:P73. – Please contact the medical library for a copy.  Silbergeld A, Lilos P, Laron Z. Effect of alendronate on bone mineral density in adult patients with Laron’s syndrome (primary growth hormone insensitivity). Abstract #P63). Annual Meeting of the Israel Endocrine Society. 2004;Abstract B:P63. – Please contact the medical library for a copy.  Silbergeld A, Lilos P, Laron Z. Foot length before and during insulin-like growth factor-I treatment of children with Laron syndrome compared to human growth hormone treatment of children with isolated growth hormone deficiency. Journal of Pediatric Endocrinology and Metabolism. 2007;20(12):1325-1328. – Please contact the medical library for a copy.  Silbergeld A, Lilos P, Laron Z. Growth of foot length during IGF-I treatment in children with Laron syndrome. (Abstract P3-633). Horm Res. 2004;62(Suppl. 2):175. – Please contact the medical library for a copy.  Silbergeld A, Lilos P, Laron Ζ. Comparative catch-up growth of height, foot and brain in children with Laron syndrome (LS) treated by IGF-I to that of children with IGHD treated by hGH (Abstract #P03-610). Horm Res. 2006;65(Suppl. 4):177. – Please contact the medical library for a copy.  Simon M WD Sarfstein R, Laron Z, Werner H. Elucidation of the signaling pathway elicited by the long-acting insulin analogues Glargine and Detemir (Abstract #D-38). The 8th Research Fair of the Sackler Faculty of Medicine. 2008;Abstract B:140. – Please contact the medical library for a copy.  Simon M WD Sarfstein R, Laron Z, Werner H. Elucidation of the signaling pathways elicited by the long-acting insulin analogues Glargine and Detemir (Abstract# P94). 37th Annual Meeting of the Israel Endocrine Society. 2008;Abstract B:P94. – Please contact the medical library for a copy.  Singer R, Dickerman Z, Sagiv M, Laron Z, Livni E. Endocrinological parameters and cell-mediated immunity postoperation for cryptorchidism. Arch Androl. 1988;20(2):153-157. doi:10.3109/01485018808987067  Sirota L, Dickerman Z, Laron Z, Weitz R, Dulitzky F. Neuroendocrine study of a male infant with septo-optic dysplasia. Isr J Med Sci. 1985;21(9):745-749. – Please contact the medical library for a copy.  Sirota P, Gil-Ad I, Hermesh H, Munitz H, Laron Z, Weizman R. Growth hormone response to TRH in families multiply affected with schizophrenia. Biol Psychiatry. 1992;31(12):1241-1244. doi:10.1016/0006-3223(92)90347-3. – Please contact the medical library for a copy.  Sivan B, Lilos P, Laron Z. Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity). Journal of Pediatric Endocrinology and Metabolism. 2003;16(4):509-520. – Please contact the medical library for a copy.  Sivan B, Lilos P, Laron Z. The effect of IGF-I deficiency and replacement therapy on the hematopoietic system of Laron syndrome patients. Annual Meeting of the Israel Endocrine Society. 2001:Abstract A18. – Please contact the medical library for a copy.  Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res. 2001;11(3):137-165. doi:10.1054/ghir.2001.0203. – Please contact the medical library for a copy.  Songini M, Casu A, Ashkenazi I, Laron Z. Seasonality of birth in children (0-14 years) and young adults (0-29 years) with type 1 diabetes mellitus in Sardinia differs from that in the general population. Journal of Pediatric Endocrinology and Metabolism. 2001;14(6):781-783. – Please contact the medical library for a copy.  Speiser PW, Rudolf MCJ, Anhalt H, et al. Consensus statement: Childhood Obesity. J Clin Endocrinol Metab. 2005;90(3):1871-1887. doi:10.1210/jc.2004-1389.  Speiser T, Laron Z, Gitter S. Growth of transplantable mammary carcinoma in mice: dependence on ovarian hormones for enhancing effect of growth hormone and prolactin. Harefuah. 1969;77(9):381-384. – Please contact the medical library for a copy.  Speiser Z, Gitter S, Laron Z. Effect of growth hormone and prolactin on mouse transplantable mammary adenocarcinoma. Experientia. 1966;22(8):523-524. doi:10.1007/bf01898668. – Please contact the medical library for a copy.  Steuerman R, Shevah O, Laron Ζ. Congenital IGF-I deficiency protects from cancer development - additional support (Abstract P2-175). ENDO 2010. 2010:73. – Please contact the medical library for a copy.  Steurman R, Shevah O, Laron Z. Congenital IGF-I deficiency protects from cancer development - additional support (Abstract). The 39th Annual Conference of the Israel Endocrine Society - Program and Abstracts Book. 2010:103. – Please contact the medical library for a copy.  Stoupel E, Keret R, Assa S, Kaufman H, Shimshoni M, Laron Z. Secretion of Growth- Hormone, Prolactin and Corticosteroids During Different Levels of Geomagnetic- Activity. Neuroendocrinology Letters. 1983;5(6):365-368. – Please contact the medical library for a copy.  Stoupel E, Shimshoni M, Ashkenazi Y, et al. Some clinical chrono-and cosmobiological correlations in solar cycle 21 (Abstract). Kardiologija. 1990:201-202. – Please contact the medical library for a copy.  Streifler J, Assa S, Karp M. Prevalence of islet cell antibodies in patients with myastenia gravis. Med Sci Res. 1990;18:788. – Please contact the medical library for a copy.  Suppression of Hypoglycemia by DL-Propranolol in Malignant Insulinoma. N Engl J Med. 1978;299(9):487-487. doi:10.1056/NEJM197808312990918. – Please contact the medical library for a copy.  Tanaka T, Cohen P, E. Clayton P, Laron Z, L. Hintz R, C. Sizonenko P. Diagnosis and management of growth hormone deficiency in childhood and adolescence – Part 2: Growth hormone treatment in growth hormone deficient children. Growth Horm IGF Res. 2002;12(5):323-341. doi:10.1016/S1096-6374(02)00045-X.  Thorner MO. Growth hormone insensitivity and obesity: Insights from human and animal models. Obes Res Clin Pract. 2009;3(1):1-52. doi:10.1016/j.orcp.2009.01.002- ASK LARON.  Topper E, Dickerman Z, Prager-Lewin R, Kaufman H, Maimon Z, Laron Z. Puberty in 24 patients with Klinefelter syndrome. Eur J Pediatr. 1982;139(1):8-12. doi:10.1007/bf00442070. – Please contact the medical library for a copy.  Topper E, Faiman G, Galatzer A, et al. Improvement of diabetes control in young diabetics by self blood glucose monitoring. In: Pediatric & Adolescent Endocrinology Vol. 11. ; 1982:110-116. – Please contact the medical library for a copy.  Topper E, Gil-Ad I, Bauman B, Josefsberg Z, Laron Z. Plasma growth hormone response to oral clonidine as compared to insulin hypoglycemia in obese children and adolescents. Hormone and Metabolic Research. 1984;16(SUPPL. 1):127-130. – Please contact the medical library for a copy.  Topper E, Karp M, Beit-halachmi N, Laron Z. The significance of glycosylated hemoglobin (GHb) determination as an index of control in juvenile diabetes patients. International Study Group on Diabetes in Children and Adolescents. 1980;Bulletin #:22-23. – Please contact the medical library for a copy.  Topper E, Karp M, Doron M, Laron Z. Glycosylated hemoglobin as an index of diabetic control in juvenile diabetes. (Hebrew). Harefuah. 1979;96:469-471. – Please contact the medical library for a copy.  Ursic-Bratina N, Battelino T, Krzisnik C, Laron-Kenet T, Ashkenazi I, Laron Z. Seasonality of birth in children (0-14 years) with type 1 diabetes mellitus in Slovenia. J Pediatr Endocrinol Metab. 2001;14(1):47-52. doi:10.1515/jpem.2001.14.1.47. – Please contact the medical library for a copy.  Ursic-Bratina N, Battelino T, Krzisnikl C, Laron-Kenet Τ, Ashkenazi I, Laron Ζ. Seasonality of birth in children (0-14 years) with Type I diabetes in Slovenia. (Abstract #112). J Pediatr Endocrinol Metab. 2000;12(Suppl. 4):1237. – Please contact the medical library for a copy.  Valevski A, Gil-Ad I, Modai I, et al. Neuroendocrine response to trihexyphenidyl in depressed patients. Clin Neuropharmacol. 1992;15(1):27-33. doi:10.1097/00002826- 199202000-00004. – Please contact the medical library for a copy.  Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet. 2000;355(9207):873-876.  Vickery BH, Lunenfeld B. CNRH Analogues in Cancer and Human Reproduction Vol. 4 : Precocious Puberty, Contraception and Safety Issues. 1990th ed. (Vickery B, Lunenfeld B, eds.).; 1990:43-52. – Please contact the medical library for a copy.  Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia. 2005;48(7):1280-1287. doi:10.1007/s00125-005-1780-9  Weets I, Kaufman L, Van der Auwera B, et al. Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8- negative males, which explains the male to female excess in incidence. Diabetologia. 2004;47(4):614-621. doi:10.1007/s00125-004-1369-8  Ben Amitai D , Lurie R, Laron Z. I-GF-1 Signalling Controls the Hair Growth Cycle and the Differentiation of Hair Shafts. J Invest Dermatol. 2006;126(9):2135.  Weinstein D, Laron Z, Werner H. Analysis of the interplay between the insulin receptor and IGF-1 receptor signaling pathways in prostate cancer (Abstract). The 39th Annual Conference of the Israel Endocrine Society - Program and Abstracts Book. 2010:114. – Please contact the medical library for a copy.  Weinstein D, Laron Z, Werner H. Long-acting insulin analogues have mitogenic and antiapoptotic activities (Abstract #P3-378). 89th Annual Meeting of The Endocrine Society. 2007:594. – Please contact the medical library for a copy.  Weinstein D, Laron Ζ, Werner H. Analysis of the interplay between the insulin receptor and IGF-1 receptor signaling pathways in prostate cancer. (Abstract P64). Growth Horm IGF Res. 2010;1(S62).  Weinstein D, Simon M, Yechezkel E, Sarfstein R, Laron Z, Werner H. Mitogenic activity and signaling pathways elicited by long-acting insulin analogues Glargine and Detemir in colon cancer derived cell lines (Abstract #P-10). GH and IGF Res. 2008;18(Suppl. 1):S29-30. – Please contact the medical library for a copy.  Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF- I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Diabetes Metab Res Rev. 2009;25(1):41-49. doi:10.1002/dmrr.912  Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. The mitogenicity of insulin analogues in vitro relative to insulin and IGF-I - Response to Kazda et al. Diabetes Metab Res Rev. 2010;26(5):348. doi:10.1002/dmrr.1096  Weitz R, Kozenitzky I, Laron Z. {The De Morsier — Kallmann Syndrome. (Hebrew)}. Harefuah. 1974;86:357-361. – Please contact the medical library for a copy.  Weitz R, Laron Z. Height and weight of children born to mothers with diabetes mellitus. Israel Journal of Medical Sciences. 1976;12(3):195-198. – Please contact the medical library for a copy.  Weizman A, Gil-Ad I, Grupper D, Tyano S, Laron Z. The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients. Psychopharmacology (Berl). 1987;93(1):122-126. doi:10.1007/bf02439598. – Please contact the medical library for a copy.  Weizman A, Gil-Ad I, Weizman R, et al. Basal plasma HGH and cortisol levels and the effect of clonidine administration in female migrainous patients. Neuropsychobiology. 1984;12(2-3):106-111. doi:10.1159/000118120. – Please contact the medical library for a copy.  Weizman R, Gil-Ad I, Hermesh H, Munitz H, Laron Z. Immunoreactive beta- endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder. Clin Neuropharmacol. 1990;13(4):297-302. doi:10.1097/00002826- 199008000-00003. – Please contact the medical library for a copy.  Weizman R, Gil-Ad I, Karp L, Laor N, Barber Y, Rehavi M. Platelet imipramine binding and plasma cortisol levels in Israeli civilians during the Gulf War. Biol Psychiatry. 1992;32(2):170-178. doi:10.1016/0006-3223(92)90020-z. – Please contact the medical library for a copy.  Weizman R, Laor N, Barber Y, et al. Impact of the Gulf War on the anxiety, cortisol, and growth hormone levels of Israeli civilians. Am J Psychiatry. 1994;151(1):71-75. doi:10.1176/ajp.151.1.71. – Please contact the medical library for a copy.  Weizman R, Laor N. CORTISOL AND GROWTH-HORMONE LEVEL IN SUBJECTS EXPOSED TO WAR. Biological Psychiatry. 1993:Abstract 437. – Please contact the medical library for a copy.  Weizman R, Weizman A, Tyano S, et al. Anorexia nervosa associated with hormonal replacement therapy in an adolescent gonadal dysgenesis. Isr J Psychiatry Relat Sci. 1982;19(1):75-80. – Please contact the medical library for a copy.  Weizman R, Weizman A, Gil-Ad I, Tyano S, Laron Z. Abnormal growth hormone (hGH) response to TRH in chronic adolescent schizophrenic patients. Brit. J. Psychiat.1982;141:582-585. – Please contact the medical library for a copy.  Werner H YE Simon M, Weinstein D, Laron Z. Insulin analogues elicit atypical IGF-I receptor-mediated signalling events (Abstract PO3-398). Horm Res. 2009;73(3):475.  Werner H YE Simon M, Weinstein D, Laron Z. Long-acting insulin analogues elicit atypical IGF-I receptor-mediated signals Abstract 0/1/WED/07). Pediatr Diabetes. 2009;10(Suppl. 11):15. – Please contact the medical library for a copy.  Werner H, Weinstein D, Yehezkel E, Laron Z. Controversies in the use of insulin analogues. Expert Opin Biol Ther. 2011;11(2):199-209. doi:10.1517/14712598.2011.540233. – Please contact the medical library for a copy.  Willis JA, Scott RS, Darlow BA, Lewy H, Ashkenazi I, Laron Z. Seasonality of birth and onset of clinical disease in children and adolescents (0-19 years) with type 1 diabetes mellitus in Canterbury, New Zealand. Journal of Pediatric Endocrinology and Metabolism. 2002;15(5):645-647. – Please contact the medical library for a copy.  Witz L, Josefsberg Z, Kaufman H, Laron Z. When should hydrocortisone therapy be instituted in children with hypopituitarism? Am J Dis Child. 1988;142(8):881-883. doi:10.1001/archpedi.1988.02150080087030. – Please contact the medical library for a copy.  Wright T HG Laron Z. Congenital IGF-I deficiency effects on dental morphology and histology in patients with Laron syndrome (Abstract). 38th Annual Meeting of the Israel Endocrine Society. 2009;Program an:54. – Please contact the medical library for a copy.  Wright T, Horsay G, Laron Z. Congenital IGF-I deficiency effects on dental morphology and histology in patients with Laron Syndrome (Abstract #P-74). GH and IGF Res. 2008;18(Suppl. 1):S49. – Please contact the medical library for a copy.  Yaniv I, Lewy H, Avrahami G, Jeison M, Stark B, Laron Z. Possible link between month of birth and childhood leukemia supports the hypothesis of an infectious etiology. Israel Medical Association Journal. 2010;12(12):776. – Please contact the medical library for a copy.  Yassur Y, Siegel R, Karp M. The detection of early retinal microangiography in juvenile diabetics by monochromatic light photography. In: Diabetic Angiopathy in Children, B. Weber, Ed. Pediatric and Adolescent Endocrinology, Vol. 9. ; 1981:181- 184. – Please contact the medical library for a copy.  Ye J, Chen RG, Ashkenazi I, Laron Z. Lack of seasonality in the month of onset of childhood IDDM (0.7-15 years) in Shanghai, China. J Pediatr Endocrinol Metab. 1998;11(3):461-464. doi:10.1515/jpem.1998.11.3.461. – Please contact the medical library for a copy.  Yehezkel E, Simon M, Weinstein D, Sarfstein R, Werner H, Laron Ζ. Insulin glargine elicits atypical, IGF-IR-mediated, signal transduction events. Diabetes. 2010;70th Annua(620-P):A169. – Please contact the medical library for a copy.  Yehezkel E, Weinstein D, Simon M, Sarfstein R, Laron Z, Werner H. Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. Diabetologia. 2010;53(12):2667-2675. doi:10.1007/s00125-010-1899-1  Yosipovitch G, Mukamel M, Karp M. Diabetic Hand Syndrome in Juvenile Diabetics. Harefuah. 1990;119(3-4):63-66. – Please contact the medical library for a copy.  Zadik Z, Ashkenazi A, Schlesinger M, Lewin S, Pertzelan A. Ketotic hypoglycemia due to pituitary hormone deficiencies. Harefuah. 1977;92:140. – Please contact the medical library for a copy.  Zadik Z, Barak Y, Levin S, Josephsberg Z, Lustmann J, Chemke J. Dermoid cysts, hypothyroidism, cleft palate, and hypodontia. J Clin Dysmorphol. 1983;1(4):24-27. – Please contact the medical library for a copy.  Zadik Z, Levin S, Prager-Lewin R, Laron Z. Gonadal dysfunction in patients with ataxia telangiectasia. Acta Paediatr Scand. 1978;67(4):477-479. doi:10.1111/j.1651- 2227.1978.tb16357.x. – Please contact the medical library for a copy.  Zadik Z, Pertzelan A, Kaufman H, Levin S, Laron Z. Gynaecomastia in two prepubertal boys with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Helv Paediatr Acta. 1979;34(2):185-187. – Please contact the medical library for a copy.  Zapf J, Morell B, Walter H, Laron Z, Froesch ER. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol. 1980;95(4):505-517. doi:10.1530/acta.0.0950505. – Please contact the medical library for a copy.  Zarchi O AJ Suissa A, Nageris B, Laron Z. Hearing deficits in patients with congenital IGF-I and GH deficiencies. 38th Annual Meeting of the Israel Endocrine Society. 2009;Program an:35. – Please contact the medical library for a copy.  Zhao H. Seasonality of birth in children with diabetes. BMJ. 2000;320(7236):716-716. doi:10.1136/bmj.320.7236.716  Zilka E, Laron Z. [The normal testicular volume in Israeli children and adolescents]. Harefuah. 1969;77(11):511-513. – Please contact the medical library for a copy.